3291 sets of genes associated with phenotypes from the curated ClinVar Gene-Phenotype Associations dataset.
Gene Set |
Description |
Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia
|
|
Hypothyroidism, central, and testicular enlargement
|
|
Trifunctional protein deficiency with myopathy and neuropathy
|
|
Endometrial carcinoma
|
A endometrial cancer that is located_in the tissue lining the uterus.
|
Bifunctional peroxisomal enzyme deficiency
|
|
Short stature, idiopathic, autosomal
|
|
X-linked ichthyosis with steryl-sulfatase deficiency
|
|
Parkinson disease 2
|
|
Fibrochondrogenesis
|
|
Phosphoglycerate dehydrogenase deficiency
|
A serine deficiency that has_material_basis_in deficiency of phosphoglycerate dehydrogenase which results in a disruption of L-serine biosynthesis.
|
Branchiootic syndrome 3
|
|
Bartter syndrome, type 3, with hypocalciuria
|
|
Preeclampsia/eclampsia 4
|
|
Preeclampsia/eclampsia 5
|
|
Dandy-Walker like malformation with atrioventricular septal defect
|
|
Myopia 21, autosomal dominant
|
|
Pachyonychia congenita, type 1
|
OMIM mapping confirmed by DO. [SN].
|
Parkinson disease 7
|
|
Impdh2 enzyme activity, variation in
|
|
Familial Mediterranean fever
|
A hypersensitivity reaction type II disease characterized by recurrent episodes of fever and acute inflammation of the membranes lining the abdomen, joints and lungs; caused by mutations in the MEFV gene, which encodes the protein pyrin.
|
Pseudohypoparathyroidism type 1C
|
Pseudohypoparathyroidism type 1c (PHP1c) is a rare type of pseudohypoparathyroidism (PHP; see this term) characterized by resistance to parathyroid hormone (PTH) and other hormones, which manifests with hypocalcemia, hyperphosphatemia and elevated PTH levels, a constellation of clinical features collectively termed Albright's hereditary osteodystrophy (AHO; see this term), but normal activity of the stimulatory protein G (Gs alpha).
|
X-linked lissencephaly 2
|
|
Transient neonatal diabetes mellitus 1
|
|
Fanconi anemia, complementation group O
|
|
Achondrogenesis type 2
|
Achondrogenesis type 2 (ACG2), a form of achondrogenesis (see this term), is a very rare and lethal skeletal dysplasia and part of the spectrum of type 2 collagen-related bone disorders (see this term), characterizedby severe micromelia, short neck with large head, small thorax, protuberant abdomen, underdeveloped lungs, distinctive facial features such as a prominent forehead, a small chin, a cleft palate (in some) and distinctive histological features of the cartilage.
|
Frontometaphyseal dysplasia
|
Frontometaphyseal dysplasia (FMD) is a form of frontootopalatodigital syndrome (see this term), characterized by anomalous ossification and skeletal patterning of the axial and appendicular skeleton, severe facial dysmorphism and conductive and sensorineural hearing loss.
|
Galactosylceramide beta-galactosidase deficiency
|
|
Premature coronary artery disease
|
|
Myopia 24, autosomal dominant
|
|
Fanconi anemia, complementation group A
|
|
METHYLMALONIC ACIDURIA, mut(-) TYPE
|
An organic acidemia that involves an accumulation of methylmalonic acid in the blood.
|
Isolated 17,20-lyase deficiency
|
|
Focal dermal hypoplasia
|
OMIM mapping confirmed by DO. [SN].
|
Bethlem myopathy
|
OMIM mapping confirmed by DO. [SN].
|
Endplate acetylcholinesterase deficiency
|
|
Jakob-Creutzfeldt disease
|
OMIM mapping confirmed by DO. [SN].
|
Thrombocytosis, benign familial microcytic
|
|
Retinal dystrophy, juvenile cataracts, and short stature syndrome
|
|
Holoprosencephaly, ectrodactyly, and bilateral cleft lip/palate
|
|
Diffuse mesangial sclerosis
|
Diffuse sclerosis of the mesangium, as manifestated by diffuse mesangial matrix expansion.
|
Multiple synostoses syndrome 3
|
|
Sepiapterin reductase deficiency
|
Dopa responsive dystonia (DRD; see this term) due to sepiapterin reductase deficiency (SRD) is a very rare neurometabolic disorder characterized by dystonia with diurnal fluctuations, axial hypotonia, oculogyric crises, and delays in motor and cognitive development.
|
Polymicrogyria, bilateral frontoparietal
|
|
Sjögren-Larsson syndrome
|
|
Hennekam lymphangiectasia-lymphedema syndrome
|
|
Peroxisome biogenesis disorder 9B
|
|
X-linked mental retardation 58
|
|
UV-sensitive syndrome 3
|
|
Methionine adenosyltransferase deficiency, autosomal recessive
|
|
Duchenne muscular dystrophy
|
A muscular dystrophy that has_material_basis_in X-linked disease caused by mutations in the DMD gene found on the X chromosome. It is characterized by rapidly progressing muscle weakness and muscle atrophy initially involving the lower extremities and eventually affecting the whole body. It affects males whereas females can be carriers. The symptoms start before the age of six and may appear at infancy.
|
Myasthenic syndrome, presynaptic, congenital, with or without motor neuropathy
|
|
Pseudohypoaldosteronism, type 2
|
Pseudohypoaldosteronism type 2 (PHA2) is a rare inherited form of hypertension characterized by hyperkalemia, hyperchloremic metabolic acidosis, normal or elevated aldosterone, low renin, and normal renal function.
|
Foveal hypoplasia and presenile cataract syndrome
|
|
Pretibial epidermolysis bullosa
|
A type of blistering that affects the skin of the tibial region.
|
Congenital myotonia, autosomal dominant form
|
|
Hyperparathyroidism 1
|
|
Short rib-polydactyly syndrome, Majewski type
|
|
Char syndrome
|
|
Pyruvate dehydrogenase E2 deficiency
|
Pyruvate dehydrogenase E2 deficiency is a very rare form of pyruvate dehydrogenase deficiency (PDHD, see this term) characterized by variable lactic acidosis and neurological dysfunction, mainly appearing during childhood.
|
Epilepsy, progressive myoclonic 6
|
|
Carbonic anhydrase va deficiency, hyperammonemia due to
|
|
Fragile X syndrome
|
A neurodegenerative disease that is characterized by moderate to severe mental retardation, macroorchidism, and distinct facial features, including long face, large ears, and prominent jaw, and has_material_basis_in a loss of FMR1 function.
|
Benign familial neonatal-infantile seizures
|
|
Arrhythmia
|
Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both.
|
Shwachman syndrome
|
Shwachman-Diamond syndrome (SDS) is a rare multisystemic syndrome characterized by chronic and usually mild neutropenia, pancreatic exocrine insufficiency associated with steatorrhea and growth failure, skeletal dysplasia with short stature, and an increased risk of bone marrow aplasia or leukemic transformation.
|
Skin/hair/eye pigmentation, variation in, 1
|
|
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET
|
|
Coenzyme Q10 deficiency
|
|
Symmetrical dyschromatosis of extremities
|
|
Thyroid hormone metabolism, abnormal
|
|
Greig cephalopolysyndactyly syndrome
|
An acrocephalosyndactylia that has_material_basis_in mutation in the GLI3 gene which results_in abnormal development located_in limb, located_in head, located_in face.
|
Arthrogryposis, mental retardation, and seizures
|
|
Melnick-Fraser syndrome
|
|
Vater association with macrocephaly and ventriculomegaly
|
|
Porencephaly 2
|
|
Deficiency of ribose-5-phosphate isomerase
|
|
Cone-rod dystrophy 19
|
|
Cone-rod dystrophy 18
|
|
Cone-rod dystrophy 16
|
|
Cone-rod dystrophy 11
|
|
Marfan's syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Kininogen deficiency, total
|
|
Melnick-Needles syndrome
|
Osteodysplasty, Melnick-Needles type (MNS) is a severe form of frontootopalatodigital syndrome (see this term) and is associated with a short stature, facial dysmorphism, osseous abnormalities involving the majority of the axial and appendicular skeleton resulting in significant effects on the craniofacial skeleton including impaired speech and masticatory problems.
|
Deafness, autosomal dominant 4
|
|
Deafness, autosomal dominant 5
|
|
Branchiootorenal syndrome 2
|
|
Blood group, john milton hagen system
|
|
Giant axonal neuropathy, autosomal dominant
|
|
Megalencephaly polymicrogyria-polydactyly hydrocephalus syndrome
|
|
PTEN hamartoma tumor syndrome
|
mutation and the involvement of derivatives of all 3 germ cell layers, manifesting with hamartomas, overgrowth and neoplasia. Currently, subsets carrying clinical diagnoses of Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus and Proteus-like syndromes and SOLAMEN syndrome (see these terms) belong to PHTS.
|
Dyschromatosis universalis hereditaria 3
|
|
ISOVALERIC ACIDEMIA, TYPE I
|
|
Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive
|
|
Lesch-Nyhan syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Lynch syndrome:Turcot syndrome
|
|
Pyknodysostosis
|
|
Thrombocytopenia, X-linked
|
|
Ocular coloboma, autosomal recessive
|
|
Irido-corneo-trabecular dysgenesis
|
|
Primary autosomal recessive microcephaly 8
|
|
6-pyruvoyl-tetrahydropterin synthase deficiency
|
|
Hereditary acrodermatitis enteropathica
|
|
Neurofibromatosis, familial spinal
|
|
Primary autosomal recessive microcephaly 2
|
|
Primary autosomal recessive microcephaly 3
|
|
Oculofaciocardiodental syndrome
|
|
Primary autosomal recessive microcephaly 1
|
|
Primary autosomal recessive microcephaly 6
|
|
Nephrogenic diabetes insipidus, X-linked
|
|
Alpha-B crystallinopathy
|
|
Myofibrillar myopathy, ZASP-related
|
|
Renal hamartomas nephroblastomatosis and fetal gigantism
|
|
Charcot-Marie-Tooth disease, X-linked dominant, 6
|
|
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies
|
|
Anonychia
|
Aplasia of the nail.
|
Robinow Sorauf syndrome
|
|
Maple syrup urine disease type 2
|
|
Hydroxykynureninuria
|
|
Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis
|
|
17q2131 microdeletion syndrome
|
A syndrome that is characterized by developmental delay, intellectual disability, muscle weakness (hypotonia), epilepsy, distinctive facial features and congenital malformations of the heart, urogenital tract and the central nervous system, and has_physical_basis_in either a chromosome 17 (17q21.31) microdeletion or a mutation in the KANSL1-gene.
|
Microphthalmia, isolated 4
|
|
Microphthalmia, isolated 7
|
|
Microphthalmia, isolated 6
|
|
Microcephaly 12, primary, autosomal recessive
|
|
Combined oxidative phosphorylation deficiency 9
|
|
Combined oxidative phosphorylation deficiency 8
|
|
Abetalipoproteinaemia
|
|
N-terminal acetyltransferase deficiency
|
An X-linked disease resulting from a deficiency in N-terminal acetyltransferase, characterized by postnatal growth failure with severe delays and dysmorphic features in boys.
|
Combined oxidative phosphorylation deficiency 1
|
|
Combined oxidative phosphorylation deficiency 7
|
|
Combined oxidative phosphorylation deficiency 6
|
|
Combined oxidative phosphorylation deficiency 5
|
|
Exudative vitreoretinopathy 5
|
|
Gaucher's disease, type 1
|
|
Congenital adrenal hyperplasia
|
A steroid inherited metabolic disorder that is characterized by adrenal insufficiency and variable degrees of hyper or hypo androgeny manifestations resulting from steroidogenic enzyme deficiency.
|
Patterned dystrophy of retinal pigment epithelium
|
|
Desbuquois syndrome
|
Desbuquois syndrome (DBQD) is an osteochondrodysplasia characterized by severe micromelic dwarfism, facial dysmorphism, joint laxity, multiple dislocations, vertebral and metaphyseal abnormalities and advanced carpotarsal ossification. Two forms have been distinguished on the basis of the presence (type 1) or the absence (type 2) of characteristic hand anomalies.
|
46,XY sex reversal 9
|
|
46,XY sex reversal 8
|
|
Microcytic anemia
|
OMIM mapping confirmed by DO. [SN].
|
Early myoclonic encephalopathy
|
|
Neutropenia, nonimmune chronic idiopathic, of adults
|
|
Congenital human immunodeficiency virus
|
|
Familial hypertrophic cardiomyopathy 9
|
|
Familial hypertrophic cardiomyopathy 7
|
|
Familial hypertrophic cardiomyopathy 6
|
|
Familial hypertrophic cardiomyopathy 4
|
|
Familial hypertrophic cardiomyopathy 3
|
|
Familial hypertrophic cardiomyopathy 2
|
|
Familial hypertrophic cardiomyopathy 1
|
|
Bronchiectasis with or without elevated sweat chloride 3
|
|
Agammaglobulinemia 2, autosomal recessive
|
|
Stargardt Disease 3
|
|
Myopathy, lactic acidosis, and sideroblastic anemia 1
|
|
Skin/hair/eye pigmentation, variation in, 8
|
|
Complement component 7 deficiency
|
NT MGI.
|
Peroxisome biogenesis disorder 3A
|
|
Microtia, hearing impairment, and cleft palate
|
|
Mental retardation, X-linked 45
|
|
Macrocephaly/autism syndrome
|
|
Charcot-Marie-Tooth disease, type 4H
|
Charcot-Marie-Tooth disease, type 4H (CMT4H) is a demyelinating CMT peripheral sensorimotor polyneuropathy
|
Nephrotic syndrome, type 9
|
|
Charcot-Marie-Tooth disease, type 4J
|
|
Hydatidiform mole
|
OMIM mapping confirmed by DO. [SN].
|
Nephrotic syndrome, type 8
|
|
Charcot-Marie-Tooth disease, type 4A
|
Charcot-Marie-Tooth disease, type 4A (CMT4A) is a severe, early-onset form of demyelinating CMT peripheral sensorimotor polyneuropathy characterized by severe motor retardation and progressive scoliosis.
|
Macular dystrophy, vitelliform, 5
|
|
Charcot-Marie-Tooth disease, type 4C
|
Charcot-Marie-Tooth disease, type 4C (CMT4C) is a demyelinating CMT peripheral sensorimotor polyneuropathy with early-onset scoliosis or kyphoscoliosis.
|
Charcot-Marie-Tooth disease, type 4D
|
Charcot-Marie-Tooth disease type 4D (CMT4D) is a severe form of Charcot-Marie-Tooth disease type 4 (see this term), a demyelinating hereditary motor and sensory neuropathy, characterized by gait disorder manifesting in the first decade of life, followed by upper limb involvement observed in the second decade , and sensorineural deafness usually manifesting in the second or third decade of life.
|
Creatine deficiency, X-linked
|
|
Charcot-Marie-Tooth disease, type 4G
|
Charcot-Marie-Tooth disease, type 4G (CMT4G) is a demyelinating CMT peripheral sensorimotor polyneuropathy.
|
Birbeck granule deficiency
|
|
Glucocorticoid deficiency 2
|
|
Czech dysplasia metatarsal type
|
|
Glucocorticoid deficiency 4
|
|
Normokalemic periodic paralysis, potassium-sensitive
|
|
Vitamin d hydroxylation-deficient rickets, type 1b
|
|
Neonatal insulin-dependent diabetes mellitus
|
|
Ataxia-telangiectasia-like disorder
|
|
Myopathy, centronuclear
|
|
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige
|
|
Norum disease
|
OMIM mapping confirmed by DO. [SN].
|
SCID due to ADA deficiency, delayed onset
|
|
Ichthyosis, spastic quadriplegia, and mental retardation
|
|
Mitochondrial diseases
|
|
Mohr-Tranebjaerg syndrome
|
A mitochondrial metabolism disease that is characterized by hearing loss that begins early in life, problems with movement, impaired vision, and behavior problems.
|
AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5
|
|
Salla disease
|
|
Worth disease
|
|
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)
|
|
Retinitis pigmentosa 20
|
|
AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3
|
|
Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
|
Tumoral calcinosis, familial, hyperphosphatemic
|
|
Deafness, digenic, GJB2/GJB3
|
|
Superoxide dismutase, elevated extracellular
|
|
Parkinson's disease
|
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)|A neurodegenerative disease that results_from degeneration of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
|
Cataract, posterior polar, 3
|
|
Neurohypophyseal diabetes insipidus
|
OMIM mapping confirmed by DO. [SN].
|
Aspartylglycosaminuria
|
OMIM mapping confirmed by DO. [SN].
|
Properdin deficiency, X-linked
|
|
Left ventricular noncompaction 10
|
|
Sacral agenesis with vertebral anomalies
|
|
Paroxysmal atrial fibrillation
|
Episodes of atrial fibrillation that typically last for several hours up to one day and terminate spontaneously.
|
Deafness, autosomal recessive 101
|
|
Deafness, autosomal recessive 103
|
|
Hypermanganesemia with dystonia, polycythemia and cirrhosis
|
|
Epiphyseal dysplasia, multiple, 3, with myopathy
|
|
Febrile seizures, familial, 4
|
|
Combined cellular and humoral immune defects with granulomas
|
|
Osteopenic nonfracture syndrome
|
|
Hereditary liability to pressure palsies
|
|
sporadic abdominal aortic aneurysm
|
|
Barakat syndrome
|
|
Raine syndrome
|
|
Ménière's disease
|
|
Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects
|
|
Spondyloperipheral dysplasia
|
|
Hyperammonemia, type III
|
|
Diamond-Blackfan anemia 11
|
|
Diamond-Blackfan anemia 10
|
|
Peroxisome biogenesis disorder 8B
|
|
Prostate cancer, hereditary, 13
|
|
Peroxisome biogenesis disorder 8A
|
|
PROPERDIN DEFICIENCY, TYPE II
|
|
Complement factor d deficiency
|
|
Telangiectasia, hereditary hemorrhagic, type 5
|
|
Ventricular fibrillation
|
Uncontrolled contractions of muscles fibers in the left ventricle not producing contraction of the left ventricle. Ventricular fibrillation usually begins with a ventricular premature contraction and a short run of rapid ventricular tachycardia degenerating into uncoordinating ventricular fibrillations.
|
Autosomal recessive hypophosphatemic vitamin D refractory rickets
|
|
Insulin resistance
|
diminished effectiveness of insulin in lowering plasma glucose levels
|
DiGeorge sequence
|
|
Wolcott-Rallison dysplasia
|
|
MACULAR CORNEAL DYSTROPHY, TYPE II
|
|
Digitorenocerebral syndrome
|
|
Thrombophilia due to protein S deficiency, autosomal recessive
|
|
Autosomal recessive cutis laxa type 1B
|
|
X-linked mental retardation, syndromic, Claes-Jensen type
|
|
Familial restrictive cardiomyopathy 1
|
|
Auditory neuropathy, autosomal recessive, 1
|
|
Hypermethioninemia with s-adenosylhomocysteine hydrolase deficiency
|
An amino acid metabolic disorder that involves an excess of the amino acid methionine, in the blood. This condition can occur when methionine is not broken down properly in the body.
|
Bullous ichthyosiform erythroderma
|
|
Gaze palsy, familial horizontal, with progressive scoliosis
|
|
Zonular pulverulent cataract 3
|
|
Sialidosis type I
|
|
Keratosis palmoplantaris striata 1
|
|
Protan defect
|
|
Hereditary cancer-predisposing syndrome:Lynch syndrome
|
|
Bare Lymphocyte Syndrome, Type II, Complementation Group D
|
|
Hypercholesterolemia, autosomal recessive
|
|
Combined d-2- and l-2-hydroxyglutaric aciduria
|
|
Leukodystrophy, hypomyelinating 3
|
|
GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT
|
|
Retinitis pigmentosa 18
|
|
Maple syrup urine disease, type 3
|
|
Methylmalonyl-CoA epimerase deficiency
|
|
Woolly hair, autosomal recessive 2, with or without hypotrichosis
|
|
Retinitis pigmentosa 12
|
|
Retinitis pigmentosa 13
|
|
Retinitis pigmentosa 10
|
|
Retinitis pigmentosa 11
|
|
Choreoacanthocytosis
|
|
Pleuropulmonary blastoma
|
A pulmonary blastoma that derives_from the lung or pleural cavity.
|
Sinoatrial node dysfunction and deafness
|
|
Retinitis pigmentosa 15
|
|
Complement component 8 deficiency type 2
|
|
Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema
|
|
Neuroblastoma 3
|
|
Amyotrophic lateral sclerosis 20
|
A type of ALS with juvenile onset caused_by mutation located_in HNRNPA1 gene located_in chromosome 12.
|
Limb-girdle muscular dystrophy-dystroglycanopathy, type C14
|
|
Diarrhea 5, with tufting enteropathy, congenital
|
|
Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like
|
|
Ataxia-telangiectasia syndrome
|
|
Testosterone 17-beta-dehydrogenase deficiency
|
|
Acute neuronopathic Gaucher's disease
|
|
Alport syndrome, autosomal recessive
|
|
Cataract 15, multiple types
|
|
Interfrontal craniofaciosynostosis
|
|
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer
|
|
Immunodeficiency 8
|
|
Alstrom syndrome
|
An autosomal recessive disease that is characterized by multiorgan dysfunction. The key features are childhood obesity, blindness due to congenital retinal dystrophy, and sensorineural hearing loss with autosomal recessive inheritance and has_material_basis_in mutations in the ALMS1 gene.
|
Hypomagnesemia 1, intestinal
|
|
Cataract, autosomal dominant, multiple types, with microcornea
|
|
Rasopathy
|
|
AMELOGENESIS IMPERFECTA, TYPE IH
|
|
Hyperinsulinism-hyperammonemia syndrome
|
Hyperinsulinism-hyperammonemia syndrome (HIHA) is the most common form of diazoxide-sensitive diffuse hyperinsulinism (see this term), characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), asymptomatic hyperammonemia and recurrent episodes of profound hypoglycemia induced by fasting and protein rich meals, requiring rapid and intensive treatment to prevent neurological sequelae.
|
Primary erythromelalgia
|
|
X-linked mental retardation 63
|
|
Acyl-CoA dehydrogenase family, member 9, deficiency of
|
|
Currarino triad
|
|
BLOOD GROUP--WALDNER TYPE
|
|
Lynch syndrome II
|
|
Joubert syndrome 17
|
|
Cardiac conduction defect, nonspecific
|
|
Lethal multiple pterygium syndrome
|
|
Non-small cell lung cancer
|
|
Acroerythrokeratoderma
|
|
Renal hypodysplasia/aplasia 2
|
|
Hyperbiliverdinemia
|
|
MORM syndrome
|
|
Zunich neuroectodermal syndrome:Zunich neuroectodermal syndrome
|
|
Familial hemiplegic migraine type 1
|
|
Vertical talus, congenital
|
|
Familial hemiplegic migraine type 3
|
|
Familial hemiplegic migraine type 2
|
|
Mental retardation, autosomal recessive 2
|
|
Mental retardation, autosomal recessive 7
|
|
Mental retardation, autosomal recessive 5
|
|
T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations
|
|
Craniodiaphyseal dysplasia, autosomal dominant
|
|
Charcot-Marie-Tooth disease, type IVF
|
|
Upshaw-Schulman syndrome
|
|
Deficiency of 2-methylbutyryl-CoA dehydrogenase
|
|
Hereditary neutrophilia
|
|
Glaucoma 1, open angle, e
|
|
Hereditary cancer-predisposing syndrome
|
|
Nemaline myopathy 3, autosomal dominant or recessive
|
|
Mucopolysaccharidosis, MPS-I-H/S
|
|
Usher syndrome, type 1C
|
|
Homocystinuria, pyridoxine-responsive
|
|
Microphthalmia syndromic 6
|
|
Inclusion body myopathy 2
|
A myositis that is characterized by slowly progressive weakness and wasting of both distal and proximal muscles, most apparent in the muscles of the arms and legs that can occur in a sporadic or hereditary forms.
|
Atrial septal defect 7 with or without atrioventricular conduction defects
|
|
Torsades de pointes
|
A type of ventricular tachycardia characterized by polymorphioc QRS complexes that change in amplitue and cycle length, and thus have the appearance of oscillating around the baseline in the EKG.
|
Amelogenesis imperfecta, hypocalcification type
|
|
Glaucoma 1, open angle, O
|
|
Usher syndrome, type 1F
|
|
Hypogonadotropic hypogonadism 12 with or without anosmia
|
|
Glaucoma 1, open angle, F
|
|
Glaucoma 1, open angle, G
|
|
Martsolf syndrome
|
|
Usher syndrome, type 1D
|
|
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
|
Erythrocytosis, familial, 4
|
|
Erythrocytosis, familial, 3
|
|
Erythrocytosis, familial, 2
|
|
epileptic encephalopathy, early infanitle, 1
|
|
Usher syndrome, type 1J
|
|
Hypercalciuric hypercalcemia
|
|
Cataract, nuclear total
|
|
Charcot-Marie-Tooth disease, dominant intermediate F
|
|
Charcot-Marie-Tooth disease, dominant intermediate E
|
|
Elliptocytosis 2
|
|
Charcot-Marie-Tooth disease, dominant intermediate C
|
|
Ectopia lentis, isolated autosomal recessive
|
|
Congenital generalized lipodystrophy type 1
|
|
Ceroid lipofuscinosis, neuronal, 13
|
|
Mental retardation with language impairment and autistic features
|
|
Glycogen storage disease type IXa1
|
|
Chromosome 2q32-q33 deletion syndrome
|
|
Warts, hypogammaglobulinemia, infections, and myelokathexis
|
|
Osteogenesis imperfecta type 15
|
|
Osteogenesis imperfecta type 12
|
|
Catecholaminergic polymorphic ventricular tachycardia
|
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe genetic arrhythmogenic disorder characterized by adrenergically induced ventricular tachycardia (VT) manifesting as syncope and sudden death.
|
Osteogenesis imperfecta type 10
|
|
Osteogenesis imperfecta type 11
|
|
Blepharophimosis-ptosis-intellectual disability syndrome
|
|
Borrone Di Rocco Crovato syndrome
|
|
Fibular hypoplasia and complex brachydactyly
|
An autosomal recessive disease that is characterised by severe reduction or absence of the fibula and complex brachydactyly.
|
Epidermodysplasia verruciformis
|
An autosomal recessive disease that results_in skin squamous cell carcinoma located_in skin, associated with a high risk of carcinoma. It is characterized by abnormal susceptibility to human papillomaviruses of the skin and has_symptom lesions on the body.
|
Hurler syndrome
|
A mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme alpha-L-iduronidase.
|
Basal ganglia calcification, idiopathic, 4
|
|
Mantle cell lymphoma
|
A B-cell lymphocytic neoplasm due to CD5 positive antigen-naive pregerminal center B-cell within the mantle zone that surrounds normal germinal center follicles.
|
Primary hypertrophic osteoarthropathy, autosomal recessive 2
|
|
X-linked severe combined immunodeficiency
|
A severe combined immunodeficiency that is a X-linked SCID caused by mutations in genes encoding common gamma chain proteins shared by the interleukin (IL-2,4,7,9,16 and21) receptors resulting in a non-functional gamma chain, defective interleukin signalling, minimal or ascent T- and NK cells and non-functional B-cells.
|
Autosomal recessive hypophosphatemic bone disease
|
|
Aortic aneurysm, familial thoracic 6
|
|
Xeroderma pigmentosum, group C
|
|
Deficiency of isobutyryl-CoA dehydrogenase
|
|
Hyperalphalipoproteinemia 2
|
|
Inflammatory bowel disease 25, autosomal recessive
|
|
Moyamoya disease 6 with achalasia
|
|
Familial X-linked hypophosphatemic vitamin D refractory rickets
|
|
Glycogen storage disease IV, congenital neuromuscular
|
|
Mental retardation, X-linked, syndromic, turner type
|
|
Leber congenital amaurosis 3
|
|
Angelman syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Leber congenital amaurosis 6
|
|
Facial paresis, hereditary congenital, 3
|
|
Leber congenital amaurosis 5
|
|
Leber congenital amaurosis 8
|
|
Leber congenital amaurosis 9
|
|
Lig4 syndrome
|
A combined T cell and B cell immunodeficiency that is caused by a mutatino in the LIG4 gene, a DNA ligase, encoding a protein essential for V(D)J recombination and DNA double-strand break (DSB) repair through nonhomologous end joining (NHEJ). Patients present with immunodeficiency and developmental and growth delay.
|
Mitochondrial DNA depletion syndrome 4B, MNGIE type
|
|
Intestinal pseudoobstruction neuronal chronic idiopathic X-linked
|
|
X-linked mental retardation 3
|
|
Wilms tumor 1
|
|
Cardiomyopathy:Cardiomyopathy
|
|
Rubinstein-Taybi syndrome 2
|
|
Hypohidrotic X-linked ectodermal dysplasia
|
|
Glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
|
Mental retardation, autosomal dominant 30
|
|
Leukoencephalopathy, progressive, with ovarian failure
|
|
Progressive pseudorheumatoid dysplasia
|
|
Hypobetalipoproteinemia, normotriglyceridemic
|
|
Hajdu-Cheney syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Hyperferritinemia cataract syndrome
|
|
Myopathy, reducing body, X-linked, early-onset, severe
|
|
Iron accumulation in brain
|
An abnormal build up of iron (Fe) in brain tissue.
|
Hereditary sideroblastic anemia
|
|
Temtamy preaxial brachydactyly syndrome
|
An autosomal recessive disease that is characterized by brachydactyly, hyperphalangism of digits, facial dysmorphism, dental anomalies, sensorineural hearing loss, delayed motor and mental development, and growth retardation and has_material_basis_in homozygous mutation in the CHSY1 gene.
|
Mitochondrial DNA depletion syndrome 2
|
|
Hyperimmunoglobulin E syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Skin/hair/eye pigmentation, variation in, 4
|
|
Skin/hair/eye pigmentation, variation in, 5
|
|
Bannayan-Riley-Ruvalcaba syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated
|
|
Pontocerebellar hypoplasia type 8
|
NT MGI.
|
Chudley-McCullough syndrome
|
|
Skin/hair/eye pigmentation, variation in, 9
|
|
Deafness, autosomal recessive 30
|
|
Poretti-boltshauser syndrome
|
|
Deafness, autosomal recessive 37
|
|
Deafness, autosomal recessive 35
|
|
Deafness, autosomal recessive 39
|
|
Charcot-Marie-Tooth disease, type 4B3
|
|
Bosch-boonstra-schaaf optic atrophy syndrome
|
|
Osteoglophonic dysplasia
|
|
Congenital glucose-galactose malabsorption
|
|
Mental retardation, anterior maxillary protrusion, and strabismus
|
|
Familial cardiomyopathy
|
|
Cerebral folate deficiency
|
A reduced concentration of 5-methyltetrahydrofolate(2-) in the cerebrospinal fluid (CSF). 5-methyltetrahydrofolate is the active folate metabolite.
|
Infantile convulsions and paroxysmal choreoathetosis, familial
|
|
Periodontitis, aggressive, 1
|
|
Frank Ter Haar syndrome
|
|
Dilated cardiomyopathy 1LL
|
|
Short stature, optic nerve atrophy, and pelger-huet anomaly
|
|
Myopathy, centronuclear, 5
|
|
Alzheimer disease, familial, 3, with spastic paraparesis and apraxia
|
|
Cutis laxa, X-linked
|
|
Charcot-Marie-Tooth disease, type 4B1
|
Charcot-Marie-Tooth disease, type 4B1 (CMT4B1) is a severe early-onset demyelinating CMT peripheral sensorimotor polyneuropathy.
|
Leukoencephalopathy, cystic, without megalencephaly
|
|
Phosphoserine aminotransferase deficiency
|
A serine deficiency that has_material_basis_in deficiency of phosphoserine aminotransferase and is characterized by low concentartions of serine and flycine in plasma and cerebrospinal fluid.
|
Androgen resistance syndrome
|
|
Brain small vessel disease with hemorrhage
|
|
Hypoparathyroidism retardation dysmorphism syndrome
|
|
Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
|
|
Holt-Oram syndrome
|
Holt-Oram syndrome (HOS) is the most common form of heart-hand syndrome (see this term) and is characterized by skeletal abnormalities of the upper limbs and mild-to-severe congenital cardiac defects.
|
Cryptorchidism, unilateral or bilateral
|
|
Insulin-resistant diabetes mellitus AND acanthosis nigricans
|
|
Severe combined immunodeficiency due to ADA deficiency
|
|
Adrenocortical insufficiency
|
|
Glaucoma, primary open angle, juvenile-onset
|
|
Epiphyseal chondrodysplasia, miura type
|
|
Failure of tooth eruption, primary
|
|
Atrichia with papular lesions
|
Atrichia with papular lesions is a rare inherited form of alopecia characterized by irreversible hair loss during the neonatal period on all hear-bearing areas of the body, later associated with the development of papular lesions all over the body and preferentially on the face and extensor surfaces of the extremities.
|
Duane syndrome type 2
|
|
Young Simpson syndrome
|
|
Frasier syndrome
|
OMIM mapping confirmed by DO. [SN].
|
C-like syndrome
|
|
Paramyotonia congenita of von Eulenburg
|
|
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
|
|
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3
|
|
Congenital sensory neuropathy with selective loss of small myelinated fibers
|
|
Autoinflammation with infantile enterocolitis
|
|
Benign familial neonatal seizures 1
|
|
Meier-Gorlin syndrome
|
An autosomal recessive disorder characterized by severe intrauterine and postnatal growth retardation, microcephaly, bilateral microtia and hypoplastic patellae.
|
Benign familial neonatal seizures 2
|
|
Dystonia 24
|
|
Pili torti-deafness syndrome
|
|
Gorlin syndrome
|
|
Hypertelorism, severe, with midface prominence, myopia, mental retardation, and bone fragility
|
|
Marshall syndrome
|
|
Palmoplantar keratoderma, nonepidermolytic, focal or diffuse
|
|
Myopathy, myosin storage
|
|
Usher syndrome, type 2C
|
|
Arylsulfatase A pseudodeficiency
|
|
Usher syndrome, type 2D
|
|
Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive
|
|
Amyotrophic lateral sclerosis 18
|
A type of ALS caused_by mutation located_in PFN1 gene located_in chromosome 17.
|
Porphyria cutanea tarda
|
An acute porphyria characterized by painful, blistering skin lesions that develop on sun-exposed skin.
|
Carnitine acylcarnitine translocase deficiency
|
Carnitine-acylcarnitine translocase (CACT) deficiency is a life-threatening, inherited disorder of fatty acid oxidation which usually presents in the neonatal period with severe hypoketotic hypoglycemia, hyperammonemia, cardiomyopathy and/or arrhythmia, hepatic dysfunction, skeletal muscle weakness, and encephalopathy.
|
Osteopetrosis, autosomal recessive 8
|
|
Gracile bone dysplasia
|
Osteocraniostenosis is a lethal skeletal dysplasia characterized by a cloverleaf skull anomaly, facial dysmorphism, limb shortness, splenic hypo/aplasia and radiological anomalies including thin tubular bones with flared metaphyses and deficient calvarial mineralization.
|
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency
|
|
Hereditary hemochromatosis
|
|
Succinyl-CoA acetoacetate transferase deficiency
|
Succinyl-CoA:3-ketoacid CoA transferase deficiency (SCOTD) is a defect in ketone body utilization characterized by severe, potentially fatal intermittent episodes of ketoacidosis.
|
Cognitive impairment with or without cerebellar ataxia
|
|
Thyrotropin-releasing hormone resistance, generalized
|
|
Carpenter syndrome
|
An acrocephalosyndactylia characterized by craniosynostosis, acrocephaly, obesity, syndactyly and polydactyly.
|
Bernard-Soulier syndrome, type A2, autosomal dominant
|
|
Duane-radial ray syndrome
|
Le résumé pour cette maladie est en cours de production. Cependant, vous pouvez accéder à d'autres données sur cette maladie à partir du menu « Informations complémentaires » situé à droite sur cette page.
|
Frontonasal dysplasia
|
|
Bardet-Biedl syndrome 19
|
|
Persistent hyperinsulinemic hypoglycemia of infancy
|
Congenital isolated hyperinsulinism (CHI), a rare endocrine disease is the most frequent cause of severe and persistent hypoglycemia in the neonatal period and early infancy and is characterized by an excessive or uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of profound hypoglycemia requiring rapid and intensive treatment to prevent neurological sequelae. CHI comprises 2 different forms: diazoxide-sensitive diffuse hyperinsulinism and diazoxide-resistant hyperinsulinism (see these terms).
|
Kallikrein, decreased urinary activity of
|
|
Carnitine palmitoyltransferase I deficiency
|
|
Tibia, hypoplasia of, with polydactyly
|
|
Immunodeficiency 18, severe combined immunodeficiency variant
|
|
Myasthenic syndrome, congenital, with pre- and postsynaptic defects
|
|
Mitochondrial complex I deficiency
|
|
White sponge nevus of cannon
|
A skin disease characterized by a defect in the normal process of keratinization of the mucosa.
|
Asphyxiating thoracic dystrophy 4
|
|
22q133 deletion syndrome
|
|
Mental retardation, autosomal dominant 24
|
|
Spondyloenchondrodysplasia with immune dysregulation
|
|
Myopathy, actin, congenital, with cores
|
|
Hyperuricemic nephropathy, familial juvenile, 2
|
|
Hypercholesterolaemia
|
|
Sudden cardiac death
|
The heart suddenly and unexpectedly stops beating resulting in death within a short time period (generally within 1 h of symptom onset).
|
Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
|
Familial cancer of breast
|
|
CHARGE association
|
A syndrome that is acterized by a pattern of congenital anomalies including choanal atresia and malformations of the heart, inner ear, and retina.
|
Hyperparathyroidism, neonatal severe
|
|
Mental retardation, autosomal dominant 28
|
|
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
|
|
X-Linked mental retardation 90
|
|
Mental retardation X-linked syndromic 5
|
|
Cutis laxa-corneal clouding-oligophrenia syndrome
|
|
Craniofacial anomalies and anterior segment dysgenesis syndrome
|
|
Aphakia, congenital primary
|
OMIM mapping confirmed by DO. [SN].
|
Bardet-Biedl syndrome 14
|
|
HNSHA due to aldolase A deficiency
|
|
Epilepsy, progressive myoclonic 5
|
|
Epilepsy, progressive myoclonic 3
|
|
Peroxisomal fatty acyl-coa reductase 1 disorder
|
|
TNF receptor-associated periodic fever syndrome (TRAPS)
|
|
Familial benign pemphigus
|
|
Platelet-activating factor acetylhydrolase deficiency
|
|
Hereditary C1 esterase inhibitor deficiency - dysfunctional factor
|
|
Metaphyseal chondrodysplasia, Jansen type
|
|
Deafness with labyrinthine aplasia microtia and microdontia (LAMM)
|
|
Waardenburg syndrome type 2A
|
|
Spastic paraplegia 46, autosomal recessive
|
|
Lipodystrophy, congenital generalized, type 3
|
|
Spastic paraplegia 48, autosomal recessive
|
|
Steel syndrome
|
|
Chromosome 1q43-q44 deletion syndrome
|
|
Lipase deficiency combined
|
|
Galactosialidosis, late infantile
|
|
Beta-thalassemia, dominant inclusion body type
|
|
Situs inversus
|
OMIM mapping confirmed by DO. [LS].
|
Rod monochromatism
|
|
Spondylometaphyseal dysplasia, Kozlowski type
|
|
Roberts-SC phocomelia syndrome
|
|
Odontoonychodermal dysplasia
|
|
Alpha trait thalassemia
|
|
RRM2B-related mitochondrial disease
|
|
Phytanic acid storage disease
|
|
Multiple Cutaneous and Mucosal Venous Malformations
|
An autosomal dominant disease that is characterized by multiple bluish cutaneous or mucosal venous lesions.
|
Gm2-gangliosidosis, adult-onset
|
|
Craniosynostosis 4
|
|
Craniosynostosis 2
|
|
Craniosynostosis 3
|
|
Congenital contractural arachnodactyly
|
|
Craniosynostosis 1
|
|
Gaucher disease
|
A sphingolipidosis characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body, especially within the bone marrow, spleen and liver.
|
Autosomal dominant torsion dystonia 4
|
|
Bloom syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Neuropathy hereditary sensory and autonomic type 1
|
|
Beta thalassemia major
|
Beta-thalassemia (BT) major is a severe early-onset form of BT (see this term) characterized by severe anemia requiring regular red blood cell transfusions.
|
Carcinoma of colon
|
A colon cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
|
Hereditary hemorrhagic telangiectasia type 2
|
|
McLeod neuroacanthocytosis syndrome
|
McLeod neuroacanthocytosis syndrome (MLS) is a form of neuroacanthocytosis (see this term) and is characterized clinically by a Huntington's disease-like phenotype with an involuntary hyperkinetic movement disorder, psychiatric manifestations and cognitive alterations, and biochemically by absence of the Kx antigen and by weak expression of the Kell antigens.
|
Microcephaly with mental retardation and digital anomalies
|
|
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis
|
|
Parkinson disease 20, early-onset
|
|
Cerebrooculofacioskeletal syndrome 4
|
|
Cerebrooculofacioskeletal syndrome 2
|
|
Nicolaides-Baraitser syndrome
|
|
Leber congenital amaurosis 11
|
|
Hypogonadotropic hypogonadism 19 with or without anosmia
|
|
Oculomelic amyoplasia
|
Distal arthrogryposis type 5 is an inherited developmental defect syndrome characterized by multiple congenital contractures of limbs, without primary neurologic and/or muscle disease that affects limb function, and ocular anomalies (ptosis, external ophtalmoplegia and/or strabismus). Intelligence is normal.
|
Peripheral neuropathy, myopathy, hoarseness, and hearing loss
|
|
Cerebellar ataxia infantile with progressive external ophthalmoplegia
|
|
5-Oxoprolinase deficiency
|
|
ABO BLOOD GROUP SYSTEM, B(A) PHENOTYPE
|
|
Lymphedema, primary, with myelodysplasia
|
|
Hemolytic anemia
|
A type of anemia caused by premature destruction of red blood cells (hemolysis).
|
Islet cell hyperplasia
|
A carbohydrate metabolic disorder that involves low blood glucose resulting from an excess of insulin.
|
Schwannomatosis 2
|
|
Asphyxiating thoracic dystrophy 5
|
|
Mental retardation, autosomal dominant 23
|
|
Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia
|
|
Asphyxiating thoracic dystrophy 2
|
|
Mental retardation, autosomal dominant 27
|
|
Glucocorticoid deficiency with achalasia
|
|
Mental retardation, autosomal dominant 29
|
|
Tetraamelia, autosomal recessive
|
|
Nager syndrome
|
Nager syndrome, also called Nager acrofacial dysostosis (NAFD) is a congenital malformation syndrome characterized by mandibulofacial dystosis (malar hypoplasia, micrognathia, external ear malformations) and variable preaxial limb defects.
|
Common variable immunodeficiency 8, with autoimmunity
|
|
Angiotensin i-converting enzyme, benign serum increase
|
|
Fleck corneal dystrophy
|
Fleck corneal dystrophy (FCD) is a rare generally asymptomatic form of stromal corneal dystrophy (see this term) characterized by multiple asymptomatic, non-progressive opacities disseminated throughout the corneal stroma with no effect on visual acuity.
|
Chédiak-Higashi syndrome
|
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive
|
|
Early infantile epileptic encephalopathy 9
|
|
Early infantile epileptic encephalopathy 8
|
|
Growth retardation, developmental delay, coarse facies, and early death
|
|
Early infantile epileptic encephalopathy 2
|
|
Early infantile epileptic encephalopathy 7
|
|
Early infantile epileptic encephalopathy 5
|
|
Early infantile epileptic encephalopathy 4
|
|
Palmoplantar keratoderma, nonepidermolytic, focal
|
|
Persistent truncus arteriosus
|
|
Deafness, autosomal recessive 25
|
|
Deafness, autosomal recessive 24
|
|
Metachromatic leukodystrophy, adult type
|
|
Deafness, autosomal recessive 23
|
|
Deafness, autosomal recessive 22
|
|
Deafness, autosomal recessive 29
|
|
Deafness, autosomal recessive 28
|
|
Dyskeratosis congenita X-linked
|
|
Osteoporosis
|
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
|
Optic atrophy 7
|
|
Porokeratosis 8, disseminated superficial actinic type
|
|
Narcolepsy 7
|
|
Kindler's syndrome
|
|
Thyroid hormone resistance, generalized, autosomal recessive
|
|
Proopiomelanocortin deficiency
|
|
Carnevale syndrome
|
|
Spondyloepimetaphyseal dysplasia with multiple dislocations
|
|
Pituitary hormone deficiency, combined
|
|
Intrinsic factor deficiency
|
|
Severe congenital neutropenia
|
A neutropenia characterized by a maturation arrest of granulopoiesis at the level or promyelocytes and early onset of severe bacterial infections.
|
21-hydroxylase deficiency
|
|
Paragangliomas 2
|
|
Paragangliomas 3
|
|
Hyperphosphatasemia with bone disease
|
|
Paragangliomas 1
|
|
Kenny syndrome
|
|
Episodic pain syndrome, familial, 2
|
|
Osteogenesis imperfecta with normal sclerae, dominant form
|
|
Cromer blood group system
|
|
Hyperpigmentation, familial progressive, 2
|
|
Epilepsy, partial, with variable foci
|
|
Primary autosomal recessive microcephaly 7
|
|
Cerebral palsy, spastic quadriplegic, 6
|
|
Cerebral palsy, spastic quadriplegic, 5
|
|
Cerebral palsy, spastic quadriplegic, 3
|
|
Chondrodysplasia with joint dislocations, GPAPP type
|
|
Cerebral palsy, spastic quadriplegic, 1
|
|
Congenital absence of salivary gland
|
|
Primary autosomal recessive microcephaly 5
|
|
Pigmented nodular adrenocortical disease, primary, 1
|
|
Pigmented nodular adrenocortical disease, primary, 2
|
|
Pigmented nodular adrenocortical disease, primary, 3
|
|
Distal hereditary motor neuronopathy 2D
|
|
Nephronophthisis 14
|
|
Charcot-Marie-Tooth disease, type 2A2
|
|
Nephronophthisis 16
|
|
Nephronophthisis 11
|
|
Inflammatory skin and bowel disease, neonatal, 2
|
|
HEMOPHILIA B(M)
|
|
Glutaryl-CoA oxidase deficiency
|
|
Chylomicron retention disease
|
Chylomicron retention disease (CRD) is a type of familial hypocholesterolemia characterized by malnutrition, failure to thrive, growth failure, vitamin E deficiency and hepatic, neurologic and ophthalmologic complications.
|
Rienhoff syndrome
|
|
Nephronophthisis 18
|
|
Usher syndrome, type 2A
|
|
Forebrain defects
|
|
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
|
|
Familial aortopathy
|
|
Periventricular nodular heterotopia 6
|
|
Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 1
|
|
Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2
|
|
Corticosterone methyloxidase type 1 deficiency
|
|
Megalencephalic leukoencephalopathy with subcortical cysts 2a
|
|
Spastic paraplegia 4, autosomal dominant
|
|
Symphalangism, proximal, 1b
|
|
Atelosteogenesis type 3
|
Atelosteogenesis III (AOIII) is a skeletal dysplasia characterized by short limbs dysmorphic facies and diagnostic radiographic findings.
|
Atelosteogenesis type 2
|
Atelosteogenesis II is a lethal perinatal bone dysplasia characterized by limb shortening, normal sized skull with cleft palate, hitchhiker thumbs, distinctive facial dysmorphism and radiographic skeletal features, caused by mutations in the diastrophic dysplasia sulfate transporter gene.
|
Atelosteogenesis type 1
|
Atelosteogenesis I is a perinatally lethal skeletal dysplasia characterized by severe short-limbed dwarfism, joint dislocations, club feet along with distinctive facies and radiographic findings.
|
Renal-hepatic-pancreatic dysplasia 2
|
|
Weaver syndrome
|
OMIM mapping confirmed by DO. [LS].
|
Osteogenesis imperfecta, recessive perinatal lethal
|
|
Acampomelic campomelic dysplasia
|
An osteochondrodysplasia that has_material_basis_in a mutation in chromosome 17 which results_in bowing in the located_in tibia or located_in femur.
|
Idiopathic hypercalcemia of infancy
|
|
Thiopurine methyltransferase deficiency
|
|
METHYLCOBALAMIN DEFICIENCY, cblG TYPE
|
|
Lynch syndrome I
|
|
Multicentric osteolysis nephropathy
|
|
Retinitis pigmentosa 28
|
|
Basal ganglia disease, biotin-responsive
|
|
Geroderma osteodysplastica
|
Geroderma osteodysplastica (GO) is characterized by lax and wrinkled skin (especially on the dorsum of the hands and feet and abdomen), progeroid features, hip dislocation, joint laxity, severe short stature/dwarfism, severe osteoporosis, vertebral abnormalities and spontaneous fractures, and developmental delay and mild intellectual deficit.
|
Coronary artery disease, autosomal dominant 2
|
|
Microphthalmia, isolated 8
|
|
Sarcoidosis, early-onset
|
|
Carnitine palmitoyltransferase II deficiency, infantile
|
|
Merosin deficient congenital muscular dystrophy
|
|
Hereditary Paraganglioma-Pheochromocytoma Syndromes
|
|
Deafness, autosomal recessive 59
|
|
Skin/hair/eye pigmentation, variation in, 10
|
|
Skin/hair/eye pigmentation, variation in, 11
|
|
Epidermolysis bullosa simplex, Koebner type
|
Non-Dowling-Meara generalized epidermolysis bullosa simplex, formerly known as epidermolysis bullosa simplex, Köbner type (EBS-K) is a generalized basal subtype of epidermolysis bullosa simplex (EBS, see this term) characterized by non-herpetiform blisters and erosions arising in particular at sites of friction.
|
Xerocytosis
|
|
Methylmalonic aciduria cblA type
|
|
Xeroderma pigmentosum, type 1
|
|
Anemia sideroblastic and spinocerebellar ataxia
|
OMIM mapping confirmed by DO. [SN].
|
Lactate dehydrogenase b deficiency
|
|
Facial dysmorphism, immunodeficiency, livedo, and short stature
|
|
Syndromic X-linked mental retardation 16
|
|
Ectodermal dysplasia/short stature syndrome
|
|
Brachydactyly type A1
|
|
Citrullinemia type I
|
|
Microphthalmia, isolated 3
|
|
Siderius X-linked mental retardation syndrome
|
|
Microphthalmia, isolated 2
|
|
Premature ovarian failure 7
|
|
Combined oxidative phosphorylation deficiency 18
|
|
Combined oxidative phosphorylation deficiency 17
|
|
Combined oxidative phosphorylation deficiency 16
|
|
Left-right axis malformations
|
|
Combined oxidative phosphorylation deficiency 14
|
|
Combined oxidative phosphorylation deficiency 13
|
|
Combined oxidative phosphorylation deficiency 12
|
|
Combined oxidative phosphorylation deficiency 11
|
|
Combined oxidative phosphorylation deficiency 10
|
|
Lymphoproliferative syndrome, ebv-associated, autosomal, 1
|
|
Nystagmus 6, congenital, X-linked
|
|
Diaphanospondylodysostosis
|
|
Minicore myopathy with external ophthalmoplegia
|
|
Occult macular dystrophy
|
A macular degeneration that is characterized by a central cone dysfunction leading to a loss of vision with a normal fundus and normal fluorescein angiography findings.
|
Kohlschutter's syndrome
|
|
X-linked mental retardation with marfanoid habitus syndrome
|
|
Phosphate transport defect
|
|
Primary hyperoxaluria, type II
|
|
Deficiency of 3-hydroxyacyl-CoA dehydrogenase
|
|
Cerebro-oculo-facio-skeletal syndrome
|
Cerebrooculofacioskeletal (COFS) syndrome is a rare genetic disorder, belonging to a family of diseases of DNA repair, characterized by a severe sensorineural involvement.
|
Fucosidosis
|
OMIM mapping confirmed by DO. [SN].
|
Epileptic encephalopathy, early infantile, 1
|
|
Vitamin D-dependent rickets, type 1
|
|
Heterotaxy, visceral, 4, autosomal
|
|
Digital arthropathy-brachydactyly, familial
|
|
Epileptic encephalopathy, early infantile, 23
|
|
Plasminogen deficiency, type I
|
|
Hypotrichosis-lymphedema-telangiectasia syndrome
|
|
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
|
|
Primary dilated cardiomyopathy
|
An intrinsic cardiomyopathy that results in damage to the myocardium causing the heart to pump blood inefficiently.|A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.|decreased function of the heart associated with cardiac enlargement and congestive heart failure
|
Peroxisome biogenesis disorder 7B
|
|
LEOPARD syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Peroxisome biogenesis disorder 7A
|
|
Ceroid lipofuscinosis neuronal 7
|
|
Hermansky-Pudlak syndrome 9
|
|
Osteopetrosis with renal tubular acidosis
|
Osteopetrosis with renal tubular acidosis is a rare disorder characterized by osteopetrosis (see this term), renal tubular acidosis (RTA), and neurological disorders related to cerebral calcifications.
|
Hermansky-Pudlak syndrome 4
|
|
Hermansky-Pudlak syndrome 5
|
|
Hermansky-Pudlak syndrome 6
|
|
Hermansky-Pudlak syndrome 7
|
|
Hypogonadotropic hypogonadism 17 with or without anosmia
|
|
Cystinosis, atypical nephropathic
|
|
Hermansky-Pudlak syndrome 3
|
|
Molybdenum cofactor deficiency, complementation group C
|
|
Molybdenum cofactor deficiency, complementation group B
|
|
Molybdenum cofactor deficiency, complementation group A
|
|
Parkinson disease 17
|
|
Parkinson disease 11
|
|
Myoglobinuria, acute recurrent, autosomal recessive
|
|
Congenital stationary night blindness, autosomal dominant 3
|
|
Parkinson disease 18
|
|
Spondyloepimetaphyseal dysplasia, Missouri type
|
A spondyloepimetaphyseal dysplasia that has_material_basis_in mutations in the MMP13 gene which results_in a pear-shaped vertebrae, abnormal metaphyseal changes, and genu varum deformities.
|
Treacher collins syndrome 1
|
|
Wiskott-Aldrich syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Episodic pain syndrome, familial, 3
|
|
Hepatic venoocclusive disease with immunodeficiency
|
|
Renal tubular acidosis, distal, autosomal recessive, with late-onset sensorineural hearing loss
|
|
Biotinidase deficiency
|
A multiple carboxylase deficiency that involves a deficiency in biotinidase.
|
Hyper-IgE syndrome
|
|
Paragangliomas 4
|
|
Afibrinogenemia, congenital
|
|
Paragangliomas 5
|
|
Keratoconus 1
|
|
Lathosterolosis
|
Lathosterolosis is an extremely rare inborn error of sterol biosynthesis characterized by facial dysmorphism, congenital anomalies (including limb and kidney anomalies), failure to thrive, developmental delay and liver disease.
|
Autosomal dominant isolated somatotropin deficiency
|
|
Triglyceride storage disease with ichthyosis
|
|
Tourette Syndrome
|
A tic disorder that is characterized by multiple physical (motor) tics and at least one vocal (phonic) tic present for more than a year.
|
Macrocephaly, macrosomia, facial dysmorphism syndrome
|
|
MEN2 phenotype: Unclassified
|
|
Metachromatic leukodystrophy
|
A sphingolipidosis characterized by the accumulation of sulfatides in cells, especially the myelin producing cells of the nervous system.
|
Rett's disorder
|
A pervasive developmental disease that is a neurological and developmental disorder that mostly occurs in females and is caused_by a mutation on the MECP2 gene on the X chromosome. Infants with Rett syndrome seem to grow and develop normally at first, but then stop developing and even lose skills and abilities.
|
Diabetes mellitus, permanent neonatal, with neurologic features
|
|
May-Hegglin anomaly
|
|
Cowden disease 5
|
|
Cowden disease 6
|
|
Bartter syndrome antenatal type 2
|
|
Hypohidrotic ectodermal dysplasia with immune deficiency
|
|
Bartter syndrome antenatal type 1
|
|
Protoporphyria, erythropoietic, X-linked
|
|
Deficiency of phosphoserine phosphatase
|
|
Isolated growth hormone deficiency type 1B
|
|
Amyotrophic lateral sclerosis type 11
|
A type of ALS caused_by mutation located_in FIG4 gene located_in chromosome 6.
|
Amyotrophic lateral sclerosis type 10
|
A type of ALS caused_by mutation located_in TARDBP gene located_in chromosome 1.
|
Deafness, congenital heart defects, and posterior embryotoxon
|
|
Amyotrophic lateral sclerosis type 12
|
A type of ALS caused_by mutation located_in OPTN gene located_in chromosome 10.
|
Glycogen storage disease type II, infantile
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7
|
|
Cutaneous amyloidosis
|
The presence of amyloid deposition in the superficial dermis.
|
Short stature, idiopathic, X-linked
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A10
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A12
|
|
Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss
|
|
Infertility associated with multi-tailed spermatozoa and excessive DNA
|
|
Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete
|
OMIM mapping confirmed by DO. [SN].
|
Gamstorp-Wohlfart syndrome
|
|
Visceral myopathy
|
|
Neutral 1 amino acid transport defect
|
|
Turcot syndrome
|
|
Walker-Warburg congenital muscular dystrophy
|
|
Orthostatic intolerance
|
|
Joubert syndrome 3
|
|
Joubert syndrome 1
|
|
Fibrosis of extraocular muscles, congenital, 3b
|
|
Joubert syndrome 7
|
|
Arrhythmogenic right ventricular dysplasia, familial, 13
|
|
Iris coloboma with ptosis, hypertelorism, and mental retardation
|
|
Long QT syndrome 1
|
|
Long QT syndrome 2
|
|
Long QT syndrome 3
|
|
Sick sinus syndrome 2, autosomal dominant
|
|
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy
|
CARASIL is a hereditary cerebral small vessel disease characterized by early-onset gait disturbances, premature scalp alopecia, ischemic stroke, acute mid to lower back pain and progressive cognitive disturbances leading to severe dementia.
|
Hyaline fibromatosis syndrome
|
|
Rigidity and multifocal seizure syndrome, lethal neonatal
|
|
Febrile seizures, familial, 11
|
|
Thrombophilia, histidine-rich glycoprotein-related
|
|
Cutis laxa with osteodystrophy
|
|
Osteogenesis imperfecta
|
An osteochondrodysplasia that has_material_basis_in a deficiency in type-I collagen which results_in brittle bones and defective connective tissue.
|
Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B14
|
|
Alopecia, neurologic defects, and endocrinopathy syndrome
|
|
Deficiency of butyryl-CoA dehydrogenase
|
|
Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive
|
|
Deafness, X-linked 5
|
|
Deafness, X-linked 4
|
|
Deafness, X-linked 2
|
|
Unclassifed
|
|
Charcot-Marie-Tooth disease, type 2A1
|
|
Charcot-Marie-Tooth disease, type IF
|
|
Charcot-Marie-Tooth disease, type IE
|
|
Charcot-Marie-Tooth disease, type ID
|
|
Charcot-Marie-Tooth disease, type IC
|
|
Charcot-Marie-Tooth disease, type IB
|
|
Charcot-Marie-Tooth disease, type IA
|
|
Hypomagnesemia 6, renal
|
|
Pseudoxanthoma elasticum
|
An autosomal recessive disease characterized by the accumulation of deposits of calcium and other minerals in elastic fibers, which are a component of connective tissue, this can result in changes in the skin, eyes, cardiovascular system and gastrointestinal system.
|
Odontohypophosphatasia
|
|
Weill-Marchesani-like syndrome
|
|
Alzheimer's disease
|
A dementia that results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting in late middle age and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid. It is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability.|A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.|A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)|A dementia which is an incurable disease of unknown cause, starting in late middle age or in old age, that results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood, that leads in advanced cases to a profound decline in cognitive and physical functioning, and that is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.
|
Netherton syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Spinocerebellar ataxia 28
|
|
Nephronophthisis 13
|
|
Craniofrontonasal dysplasia
|
OMIM mapping confirmed by DO. [SN].
|
Anhidrotic ectodermal dysplasia with immune deficiency
|
|
Limb-girdle muscular dystrophy, type 2S
|
|
Bartter syndrome, type 4b
|
|
Nephronophthisis 12
|
|
North american indian childhood cirrhosis
|
|
Feingold syndrome
|
Feingold syndrome (FS), also known as oculo-digito-esophageal-duodenal (ODED) syndrome, is a rare inherited malformation syndrome characterized by microcephaly, short stature and numerous digital anomalies and is comprised of two subtypes: FS type 1 (FS1) and FS type 2 (FS2) (see these terms). FS1 is by far the most common form while FS2 has only been reported in 3 patients and has the same clinical characteristics as FS1, apart from the absence of gastrointestinal atresia and short palpebral fissures.
|
Mullerian aplasia and hyperandrogenism
|
|
Spinocerebellar ataxia autosomal recessive 1
|
|
Premature ovarian failure 4
|
|
Premature ovarian failure 5
|
|
Premature ovarian failure 6
|
|
Limb-girdle muscular dystrophy, type 2L
|
|
Premature ovarian failure 8
|
|
Limb-girdle muscular dystrophy, type 2B
|
|
Limb-girdle muscular dystrophy, type 2A
|
|
Limb-girdle muscular dystrophy, type 2F
|
|
Limb-girdle muscular dystrophy, type 2E
|
|
Limb-girdle muscular dystrophy, type 2D
|
|
Schindler disease, type 1
|
Alpha-N-acetylgalactosaminidase (NAGA) deficiency type 1 is a very rare and severe type of NAGA deficiency (see this term) characterized by infantile neuroaxonal dystrophy.
|
X-linked infantile nystagmus
|
|
Schindler disease, type 3
|
Alpha-N-acetylgalactosaminidase (NAGA) deficiency type 3 is a rare clinically heterogeneous type of NAGA deficiency (see this term) with developmental, neurologic and psychiatric manifestations presenting at an intermediate age.
|
Absent corpus callosum cataract immunodeficiency
|
|
Hodgkin lymphoma
|
A lymphoma that is marked by the presence of a type of cell called the Reed-Sternberg cell.
|
Multiple endocrine neoplasia, type 2b
|
An autosomal dominant disease characterized by medullary thyroid carcinoma, pheochromocytoma, multiple mucosal neuromas and intestinal ganglioneuromas, and often a marfanoid habitus and other skeletal abnormalities.
|
Autosomal dominant nocturnal frontal lobe epilepsy
|
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a seizure disorder characterized by intermittent dystonia and/or choreoathetoid movements that begin during sleep. The clusters of nocturnal motor seizures are often stereotyped and brief.
|
Ventricular septal defect 3
|
|
Ventricular septal defect 1
|
|
Epilepsy, progressive myoclonic 4, with or without renal failure
|
|
Cystinosis
|
|
Knuckle pads, deafness AND leukonychia syndrome
|
|
Short-sleeper
|
|
Familial benign hypercalcemia
|
Familial hypocalciuric hypercalcemia (FHH) is a generally asymptomatic genetic disorder of phosphocalcic metabolism characterized by lifelong moderate hypercalcemia along with normo- or hypocalciuria and elevated plasma parathyroid hormone (PTH) concentration.
|
Niemann-pick disease, intermediate, protracted neurovisceral
|
|
Parkinson disease 6, autosomal recessive early-onset
|
|
Congenital amegakaryocytic thrombocytopenia
|
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare inherited bone marrow failure syndrome characterized by an isolated and severe decrease in the number of platelets and megakaryocytes during the first years of life that develops into bone marrow failure with pancytopenia later in childhood.
|
Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency
|
|
Bronchiectasis with or without elevated sweat chloride 2
|
|
3 Methylcrotonyl-CoA carboxylase 1 deficiency
|
|
Atrial fibrillation, familial, 6
|
|
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract
|
|
Waardenburg syndrome type 4B
|
|
Heart block, nonprogressive
|
|
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome
|
|
Pseudo von Willebrand disease
|
Platelet type Von Willebrand disease (PT-VWD) is a bleeding disorder characterized by mild to moderate mucocutaneous bleeding, which becomes more pronounced during pregnancy or following ingestion of drugs that have anti-platelet activity. PT-VWD is due to hyperresponsive platelets, resulting in thrombocytopenia.
|
Ceroid lipofuscinosis neuronal 4B autosomal dominant
|
|
Usher syndrome, type 1
|
|
Deficiency of hyaluronoglucosaminidase
|
|
Native American myopathy
|
Native American myopathy (NAM) is a neuromuscular disorder characterized by weakness, arthrogryposis, kyphoscoliosis, short stature, cleft palate, ptosis and susceptibility to malignant hyperthermia during anesthesia.
|
Hyperphenylalaninemia, bh4-deficient, d
|
|
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE
|
|
Acrodysostosis
|
A dysostosis that results_in shortening of interphalangeal joints located_in hand or located_in foot along with mental deficiency.
|
Left ventricular noncompaction cardiomyopathy
|
Left ventricular non-compaction (LVNC) is characterized by prominent left ventricular trabeculae and deep inter-trabecular recesses. The myocardial wall is often thickened with a thin, compacted epicardial layer and a thickened endocardial layer. In some patients, LVNC is associated with left ventricular dilatation and systolic dysfunction, which can be transient in neonates.
|
Pheochromocytoma
|
Pheochromocytomas (also known as chromaffin tumors) produce, store, and secrete catecholamines. Pheochromocytomas usually originate from the adrenal medulla but may also develop from chromaffin cells in or about sympathetic ganglia. A common symptom of pheochromocytoma is hypertension owing to release of catecholamines.
|
Sandhoff disease, juvenile type
|
|
Spermatogenic failure 3
|
|
Amyotrophic lateral sclerosis type 1
|
The most common type of familial ALS caused_by mutation located_in SOD1 gene located in chromosome 21.
|
Amyotrophic lateral sclerosis type 2
|
A type of ALS with juvenile onset caused_by mutation located_in alsin gene located_in chromosome 2.
|
Osteoporosis with pseudoglioma
|
|
Amyotrophic lateral sclerosis type 4
|
A type of ALS with juvenile onset caused_by mutation located_in senataxin gene (SETX) located_in chromosome 9.
|
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps
|
|
Amyotrophic lateral sclerosis type 6
|
A type of ALS caused_by mutation located_in FUS gene located_in chromosome 16.
|
Hereditary fructosuria
|
|
Sulfite oxidase deficiency, isolated
|
|
Familial visceral amyloidosis, Ostertag type
|
|
Generalized arterial calcification of infancy 2
|
|
Richieri Costa Pereira syndrome
|
|
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia
|
|
Darier disease, segmental
|
|
Hereditary neuralgic amyotrophy
|
|
Autoimmune lymphoproliferative syndrome, type 2
|
|
Bartter syndrome type 4
|
Infantile Bartter syndrome with deafness, a phenotypic variant of Bartter syndrome (see this term) is characterized by maternal polyhydramnios, premature delivery, polyuria and sensorineural deafness and is associated with hypokalemic alkalosis, increased levels of plasma renin and aldosterone, low blood pressure, and vascular resistance to angiotensin II.
|
Bartter syndrome type 3
|
Classic Bartter syndrome is a type of Bartter syndrome (see this term), characterized by a milder clinical picture than the antenatal/infantile subtype, and presenting with failure to thrive, hypokalemic alkalosis, increased levels of plasma renin and aldosterone, low blood pressure and vascular resistance to angiotensin II.
|
Ciliary dyskinesia, primary, 9
|
|
Ciliary dyskinesia, primary, 3
|
|
Thrombocytopenia 4
|
|
Ciliary dyskinesia, primary, 7
|
|
Ciliary dyskinesia, primary, 6
|
|
Ciliary dyskinesia, primary, 5
|
|
Sclerosteosis 2
|
|
METHYLMALONIC ACIDURIA, mut(0) TYPE
|
|
Myasthenic syndrome, congenital, fast-channel
|
|
Inclusion body myopathy with early-onset paget disease and frontotemporal dementia
|
|
Naxos disease
|
|
Dementia familial British
|
|
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)
|
|
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)
|
|
Severe autosomal recessive muscular dystrophy of childhood - North African type
|
|
Spastic paraplegia 18
|
|
Macular corneal dystrophy Type I
|
|
Spastic paraplegia 15
|
|
Spondyloepiphyseal dysplasia, kimberley type
|
|
VACTERL association
|
A syndrome that is characterized by the presence of at least three of the following: vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and limb abnormalities.
|
Plasminogen activator inhibitor type 1 deficiency
|
|
Spastic paraplegia 13
|
|
Spastic paraplegia 12
|
|
Wilson-Turner X-linked mental retardation syndrome
|
|
Multicentric osteolysis, nodulosis and arthropathy
|
|
Deafness, without vestibular involvement, autosomal dominant
|
|
Stapes ankylosis with broad thumb and toes
|
|
Cataract, autosomal recessive congenital 2
|
|
Amyotrophic lateral sclerosis 1, autosomal recessive
|
|
Costello syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Corneal dystrophy and perceptive deafness
|
|
Chondrodysplasia punctata 2 X-linked dominant
|
|
Retinitis pigmentosa 7
|
|
Cataract, zonular
|
|
Pseudohypoaldosteronism type 2B
|
|
Bietti crystalline corneoretinal dystrophy
|
OMIM mapping confirmed by DO. [SN].
|
Chromophobe renal cell carcinoma
|
A renal cell carcinoma that has_material_basis_in chromophobe cell that appear pale when viewed under microscope, but that are larger and display different features than clear cells.
|
Pyruvate dehydrogenase phosphatase deficiency
|
Pyruvate dehydrogenase phosphatase deficiency is a very rare subtype of pyruvate dehydrogenase deficiency (PDHD, see this term) characterized by lactic acidemia in the neonatal period.
|
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay
|
|
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia
|
|
Combined oxidative phosphorylation deficiency 22
|
|
Combined oxidative phosphorylation deficiency 20
|
|
Combined oxidative phosphorylation deficiency 21
|
|
Ochoa syndrome
|
An autosomal recessive disease that is characterized by inverted facial expressions in association with a severe and early-onset form of dysfunctional urinary voiding.
|
Monoamine oxidase A deficiency
|
Monoamine oxidase-A deficiency is a very rare recessive X-linked biogenic amine metabolism disorder characterized clinically by mild intellectual deficit, impulsive aggressiveness, and sometimes violent behavior and presenting from childhood.
|
Arrhythmogenic right ventricular dysplasia, familial, 11, with mild palmoplantar keratoderma and woolly hair
|
|
Factor V deficiency
|
OMIM mapping confirmed by DO. [SN].
|
X-linked mental retardation 18
|
|
Orotic aciduria
|
A pyrimidine metabolic disorder that is characterized by an excessive secretion of orotic acid in urine.
|
Von Hippel-Lindau syndrome:Hereditary cancer-predisposing syndrome
|
|
Debrisoquine, poor metabolism of
|
|
Fetal hemoglobin quantitative trait locus 1
|
|
Vitamin D-dependent rickets, type 2
|
|
Fetal hemoglobin quantitative trait locus 5
|
|
Mental retardation, X-linked, syndromic, raymond type
|
|
Cystic fibrosis
|
An autosomal recessive disease that is characterized by the buildup of thick, sticky mucus that can damage many organs.
|
Familial porencephaly
|
|
Bruck syndrome 1
|
|
Bruck syndrome 2
|
|
Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness
|
|
Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant
|
|
Schizophrenia 15
|
|
Thyroid hormone resistance, generalized, autosomal dominant
|
|
Epilepsy, nocturnal frontal lobe, 5
|
|
Achalasia-alacrima syndrome
|
|
46,XY sex reversal, type 3
|
|
Hyperprolactinemia
|
An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood.
|
Cryptophthalmos syndrome
|
|
Adenine phosphoribosyltransferase deficiency
|
Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive (AR) disorder characterized by the formation and hyperexcretion of 2,8-dihydroxyadenine (2,8-DHA) in urine, causing urolithiasis and crystalline nephropathy.
|
Diarrhea 3, secretory sodium, congenital, syndromic
|
|
Severe congenital neutropenia 3, autosomal recessive
|
|
Familial hypertrophic cardiomyopathy 17
|
|
Familial hypertrophic cardiomyopathy 15
|
|
Familial hypertrophic cardiomyopathy 14
|
|
Familial hypertrophic cardiomyopathy 13
|
|
Familial hypertrophic cardiomyopathy 12
|
|
Familial hypertrophic cardiomyopathy 10
|
|
Hypocalcemia, autosomal dominant 2
|
|
Hypocalcemia, autosomal dominant 1
|
|
Hydrocephalus, nonsyndromic, autosomal recessive 2
|
|
Epidermolysis bullosa simplex with pyloric atresia
|
Epidermolysis bullosa simplex with pyloric atresia (EBS-PA) is a basal subtype of epidermolysis bullosa simplex (EBS, see this term) characterized by generalized severe blistering with widespread congenital absence of skin and pyloric atresia.
|
Charcot-Marie-Tooth disease, axonal, type 2s
|
|
Charcot-Marie-Tooth disease, axonal, type 2r
|
|
Charcot-Marie-Tooth disease, axonal, type 2q
|
|
Hypocalcemia, autosomal dominant
|
|
Nijmegen breakage syndrome-like disorder
|
|
Hypocalciuric hypercalcemia, familial, type 1
|
|
Ehlers-Danlos-like syndrome due to tenascin-X deficiency
|
|
Infantile myofibromatosis 1
|
|
Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
|
Short-rib thoracic dysplasia 11 with or without polydactyly
|
|
Brugada syndrome 6
|
|
Brugada syndrome 5
|
|
Brugada syndrome 4
|
|
Brugada syndrome 2
|
|
Brugada syndrome 1
|
|
Ovarian hyperstimulation syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Otofaciocervical syndrome 2
|
|
Kaufman oculocerebrofacial syndrome
|
|
Stickler syndrome, type 5
|
|
Stickler syndrome, type 4
|
|
Glutamate formiminotransferase deficiency
|
|
Stickler syndrome, type 2
|
|
Hypoglycemia with deficiency of glycogen synthetase in the liver
|
|
Diamond-Blackfan anemia 8
|
|
Renal tubular acidosis, distal, autosomal dominant
|
|
Cone-rod dystrophy
|
A retinal degeneration that is an inherited progressive disease that causes deterioration of the cone and rod photoreceptor cells and often results in blindness.
|
Diamond-Blackfan anemia 3
|
|
Renal tubular acidosis, distal, autosomal recessive
|
|
Diamond-Blackfan anemia 1
|
|
Diamond-Blackfan anemia 7
|
|
Cone-rod dystrophy 3
|
|
Noonan syndrome and Noonan-related syndrome
|
|
Arterial calcification of infancy
|
A vascular disease that is characterized by generalized calcification of the arterial internal elastic lamina, leading to rupture of the lamina and occlusive changes in the tunica intima with stenosis and decreased elasticity of the vessel wall.
|
Branchiooculofacial syndrome
|
An autosomal dominant disease that is characterized by low birth weight and growth retardation, bilateral branchial clefts.
|
Karak syndrome
|
|
LEUKOCYTE ADHESION DEFICIENCY, TYPE III
|
Leukocyte adhesion deficiency type III (LAD-III) is a form of LAD (see this term) characterized by both severe bacterial infections and a severe bleeding disorder.
|
Sclerosteosis
|
A hyperostosis characterized by excessive bone formation most prominent in the skull, mandible, clavicle, ribs and diaphyses of long bones; bone formation occurs throughout life.
|
Retinoblastoma
|
A retinal cell cancer and malignant neoplasm of retina and neuroblastoma and neuroendocrine tumors that derives_from the tissues of the retina.
|
Long QT syndrome 12
|
|
Long QT syndrome 13
|
|
Long QT syndrome 10
|
|
Cone-rod dystrophy 6
|
|
Follicle-stimulating hormone deficiency, isolated
|
|
Hermansky Pudlak syndrome 2
|
|
familial hyperinsulinism
|
|
X-linked mental retardation, syndromic 14
|
|
Juvenile myelomonocytic leukemia
|
OMIM mapping confirmed by DO. [SN].
|
alpha Thalassemia
|
Alpha thalassemia is a thalassemia involving the genes HBA1and HBA2 hemoglobin genes.
|
Spastic paraplegia 54, autosomal recessive
|
|
Tarsal carpal coalition syndrome
|
An autosomal dominant disease that is characterized by fusion of the carpals, tarsals, and phalanges, short first metacarpals causing brachydactyly; and humeroradial fusion.
|
Juvenile primary lateral sclerosis
|
Juvenile primary lateral sclerosis (JPLS) is a very rare motor neuron disease characterized by progressive upper motor neuron dysfunction leading to loss of the ability to walk with wheelchair dependence, and subsequently, loss of motor speech production.
|
Fanconi anemia, complementation group Q
|
|
Neurofibromatosis, type 2
|
|
Lattice corneal dystrophy Type I
|
Type I lattice corneal dystrophy (LCDI) is a frequent form of stromal corneal dystrophy (see this term) characterized by a network of delicate interdigitating branching filamentous opacities within the cornea with progressive visual impairment and no systemic manifestations.
|
L-2-hydroxyglutaric aciduria
|
An 2-hydroxyglutaric aciduria that involves damage to cerebellum affecting movement coordination resulting in problems with balance and muscle coordination (ataxia).
|
Neurofibromatosis, type 1
|
Neurofibromatosis type 1 (NF1) is a clinically heterogeneous, neurocutaneous, genetic disorder characterized by café-au-lait spots, iris Lisch nodules, axillary and inguinal freckling, and multiple neurofibromas.
|
Apparent mineralocorticoid excess
|
Apparent mineralocorticoid excess (AME) is a rare form of pseudohyperaldosteronism characterized by very early-onset and severe hypertension, associated with low renin levels and hypoaldosteronism.
|
Becker muscular dystrophy
|
OMIM mapping confirmed by DO. [SN].
|
Parkinson disease 1
|
|
Fanconi anemia, complementation group M
|
|
Fanconi anemia, complementation group N
|
|
Parkinson disease 5
|
|
Jankovic Rivera syndrome
|
|
Parkinson disease 9
|
|
Fanconi anemia, complementation group E
|
|
Fanconi anemia, complementation group F
|
|
Fanconi anemia, complementation group G
|
|
Arrhythmogenic right ventricular cardiomyopathy, type 9
|
|
Nakajo syndrome
|
|
Arrhythmogenic right ventricular cardiomyopathy, type 8
|
|
Ganglioside sialidase deficiency
|
|
Episodic ataxia, type 6
|
Episodic ataxia type 6 (EA6) is an exceedingly rare form of Hereditary episodic ataxia (see this term) with varying degrees of ataxia and associated findings including slurred speech, headache, confusion and hemiplegia.
|
Lynch syndrome:Hereditary cancer-predisposing syndrome
|
|
Juvenile neuronal ceroid lipofuscinosis
|
|
Ataxia, spastic, 4, autosomal recessive
|
|
Leiner disease
|
|
C1q deficiency
|
|
Hemochromatosis type 4
|
Hemochromatosis type 4 (also called ferroportin disease) is a form of rare hereditary hemochromatosis (HH; see this term), a group of diseases characterized by excessive tissue iron deposition of genetic origin.
|
Hemochromatosis type 3
|
Type 3 hemochromatosis is a form of rare hereditary hemochromatosis (HH) (see this term), a group of diseases characterized by excessive tissue iron deposition of genetic origin.
|
Myopathy, lactic acidosis, and sideroblastic anemia 2
|
|
Morbid obesity
|
|
Chromosome Xq28 deletion syndrome
|
|
Fanconi-Bickel syndrome
|
|
Surfactant metabolism dysfunction, pulmonary, 5
|
|
Immunodeficiency with hyper IgM type 5
|
|
Diabetes mellitus
|
A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.|A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
|
short QT syndrome
|
An autosomal dominant disease that is characterized by heart arrhythmia defined as a short QT interval on an EKG (less than 300 ms) that does not significantly change with heart rate, tall and peaked T waves, and a structurally normal heart.
|
Immunodeficiency with hyper IgM type 1
|
|
Microcephaly 10, primary, autosomal recessive
|
|
Immunodeficiency with hyper IgM type 3
|
|
Immunodeficiency with hyper IgM type 2
|
|
Interferon gamma receptor deficiency
|
|
Idiopathic fibrosing alveolitis, chronic form
|
|
Platelet glycoprotein IV deficiency
|
|
Smith-Lemli-Opitz syndrome
|
OMIM mapping confirmed by DO. [LS].
|
Epileptic encephalopathy, childhood-onset
|
|
Arrhythmogenic right ventricular cardiomyopathy, type 11
|
|
Arrhythmogenic right ventricular cardiomyopathy, type 10
|
|
Von Hippel-Lindau syndrome
|
OMIM mapping confirmed by DO. [LS].
|
Arrhythmogenic right ventricular cardiomyopathy, type 12
|
|
Macular degeneration, early-onset
|
|
Polycystic kidney disease 2
|
|
Joubert syndrome 10
|
|
Joubert syndrome 13
|
|
Joubert syndrome 14
|
|
Joubert syndrome 16
|
|
DFNA 2 Nonsyndromic Hearing Loss
|
|
N-acetylaspartate deficiency
|
|
Adenylosuccinate lyase deficiency
|
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited disorder of purine metabolism. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy.
|
Usher syndrome, type 1B
|
|
Microphthalmia syndromic 5
|
|
Dowling-degos disease 4
|
|
Congenital dyserythropoietic anemia, type I
|
Congenital dyserythropoietic anemiatype I (CDA I) is a hematologic disorder of erythropoiesis characterized by moderate to severe macrocytic anemia occasionally associated with limb or nail deformities and scoliosis.
|
Heterotopia, periventricular, autosomal recessive
|
|
Usher syndrome, type 1G
|
|
Tyrosinemia type 2
|
|
Spastic paraplegia 5A
|
|
Metachondromatosis
|
Metachondromatosis (MC) is a rare disorder characterized by the presence of both multiple enchondromas and osteochondroma-like lesions.
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative
|
|
Microphthalmia syndromic 9
|
|
Atrial septal defect 2
|
|
Multiple fibrofolliculomas
|
|
Transposition of great arteries
|
cardiovascular structural anomaly in which the aorta arises from the right ventricle while the pulmonary artery arises from the left ventricle
|
Tyrosinemia type I
|
A tyrosinemia that has_material_basis_in deficiency of the enzyme fumarylacetoacetate hydrolase resulting in an increase in fumarylacetoacetate which inhibits previous steps in tyrosine degradation leading to an accumulation of tyrosine in the body.
|
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency
|
|
Ehlers-Danlos syndrome progeroid type
|
An Ehlers-Danlos syndrome that is characterized by aged appearance, developmental delay, short stature, craniofacial disproportion, generalized osteopenia, defective wound healing, hypermobile joints, hypotonic muscles, and loose but elastic skin and has_material_basis_in compound heterozygous mutation in the B3GALT6 gene.
|
Neuropathy, hereditary motor and sensory, Okinawa type
|
|
Cardiomyopathy, restrictive
|
|
Rhegmatogenous retinal detachment, autosomal dominant
|
|
3-Methylglutaconic aciduria type 2
|
A lipid metabolism disorder that has_material_basis_in X-linked inheritance of the tafazzin gene and is characterized by decreased production of an enzyme required to produce cardiolipin.
|
Larsen syndrome, dominant type
|
|
Triosephosphate isomerase deficiency
|
A glucose metabolism disorder that is characterized by chronic haemolytic anaemia, cardiomyopathy, susceptibility to infections and severe neurological dysfunction, and has_physical_basis_in the triosephosphate isomerase enzyme (TPI1) gene inherited as an autosomal recessive trait.
|
Meconium ileus
|
Obstruction of the intestine due to abnormally thick meconium.
|
Neurofibrosarcoma
|
|
Gaucher disease, atypical, due to saposin C deficiency
|
|
Harderoporphyria
|
|
Dominant hereditary optic atrophy
|
|
Spermatogenic failure 9
|
|
Congenital adrenal hypoplasia, X-linked
|
|
Thrombocytopenia 2
|
|
Platelet-type bleeding disorder 11
|
|
Hyperimmunoglobulin D with periodic fever
|
|
Platelet-type bleeding disorder 15
|
|
Platelet-type bleeding disorder 17
|
|
Platelet-type bleeding disorder 16
|
|
Ehlers-Danlos syndrome, musculocontractural type
|
Ehlers-Danlos syndrome, musculocontractural type (MCEDS) is a form of Ehlers-Danlos syndrome (EDS; see this term) characterized by distinct craniofacial features, multiple contractures, progressive joint and skin laxity, adducted thumb, talipes equinovarus, hemorrhagic diathesis and multisystem fragility-related manifestations.
|
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis
|
|
Cone dystrophy 4
|
|
Cone dystrophy 3
|
|
Primary open angle glaucoma
|
OMIM mapping confirmed by DO. [SN].
|
Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency
|
|
Persistent hyperplastic primary vitreous, autosomal recessive
|
|
Cardiac valvular dysplasia, X-linked
|
|
Temtamy syndrome
|
Temtamy syndrome is a very rare congenital genetic neurological disorder characterized by agenesis/hypoplasia of corpus callosum with developmental abnormalities, ocular disorders, and variable craniofacial and skeletal abnormalities.
|
Birk Barel mental retardation dysmorphism syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Focal segmental glomerulosclerosis 8
|
|
Alport syndrome, X-linked recessive
|
|
Focal segmental glomerulosclerosis 2
|
|
Focal segmental glomerulosclerosis 3
|
|
Aromatase deficiency
|
Aromatase deficiency disrupts the synthesis of estradiol, resulting in hirsutism of mothers during gestation of an affected child; pseudohermaphroditism and virilization in women; and tall stature, osteoporosis and obesity in men.
|
Focal segmental glomerulosclerosis 1
|
|
Focal segmental glomerulosclerosis 6
|
|
Focal segmental glomerulosclerosis 7
|
|
Focal segmental glomerulosclerosis 5
|
|
Retinitis pigmentosa 42
|
|
Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant
|
|
Megaloblastic anemia due to inborn errors of metabolism
|
|
Hyperphosphatasia with mental retardation syndrome 2
|
|
Hyperphosphatasia with mental retardation syndrome 3
|
|
Hyperphosphatasia with mental retardation syndrome 1
|
|
Hyperphosphatasia with mental retardation syndrome 4
|
|
Hyperphosphatasia with mental retardation syndrome 5
|
|
Microcephaly, short stature, and impaired glucose metabolism
|
|
Hereditary factor II deficiency disease
|
|
Mitochondrial complex III deficiency
|
|
Heterotopia
|
|
Factor xiii, a subunit, deficiency of
|
|
Adenomatous polyposis coli:Gardner syndrome
|
|
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
|
|
Spastic paraplegia 11, autosomal recessive
|
|
Mitochondrial complex III deficiency, nuclear type 5
|
|
Hemorrhagic destruction of the brain, subependymal calcification, and cataracts
|
|
Mitochondrial complex III deficiency, nuclear type 2
|
|
Pulmonary hypertension, primary, fenfluramine-associated
|
|
Jervell and Lange-Nielsen syndrome 2
|
|
Glycogen storage disease 0, muscle
|
|
Lethal congenital contracture syndrome 5
|
|
Laron-type isolated somatotropin defect
|
|
Insulin-like growth factor 1 resistance to
|
|
Hypertrichotic osteochondrodysplasia
|
|
3-methylcrotonyl CoA carboxylase 2 deficiency
|
|
Sensorineural deafness with hypertrophic cardiomyopathy
|
|
Progressive intrahepatic cholestasis
|
|
Congenital secretory diarrhea, chloride type
|
|
Brachydactyly type A2
|
|
Amish lethal microcephaly
|
Amish lethal microcephaly is a very rare syndrome characterized by extreme microcephaly and early death, within the first year.
|
Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form
|
|
Hyperinsulinemic hypoglycemia familial 3
|
|
Hyperalphalipoproteinemia
|
An elevated concentration of high-density lipoprotein cholesterol (HDL) in the blood.
|
Leprechaunism syndrome
|
|
Beta-D-mannosidosis
|
|
Fanconi anemia, complementation group I
|
|
Spinal muscular atrophy, type II
|
|
Simpson-Golabi-Behmel syndrome
|
An X-linked disease characterized by pre- and postnatal overgrowth and craniofacial, skeletal, cardiac and renal abnormalities.
|
Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly
|
|
Metachromatic leukodystrophy, mild
|
|
Subacute neuronopathic Gaucher's disease
|
|
Thiel-Behnke corneal dystrophy
|
Thiel-Behnke corneal dystrophy (TBCD) is a rare form of superficial corneal dystrophy characterized by sub-epithelial honeycomb-shaped corneal opacities in the superficial cornea, and progressive visual impairment.
|
Radin blood group
|
|
Spermatogenic failure 14
|
|
Generalized dominant dystrophic epidermolysis bullosa
|
Generalized dominant dystrophic epidermolysis bullosa (DDEB-gen) is a subtype of dystrophic epidermolysis bullosa (DEB, see this term), formerly known as DDEB, Pasini and Cockayne-Touraine types, characterized by generalized blistering, milia formation, atrophic scarring, and dystrophic nails.
|
Spermatogenic failure 12
|
|
Spermatogenic failure 13
|
|
Spermatogenic failure 11
|
|
Spastic paraplegia 57, autosomal recessive
|
|
Osteochondritis dissecans
|
An ischemic bone disease that results_in necrosis located_in epiphysis.
|
Hemolytic anemia due to hexokinase deficiency
|
|
Febrile seizures, familial, 3b
|
|
XFE progeroid syndrome
|
|
Macrocephaly, alopecia, cutis laxa, and scoliosis
|
|
Spinocerebellar ataxia, autosomal recessive 7
|
|
Primary ciliary dyskinesia 24
|
|
Hypomyelination and Congenital Cataract
|
|
Primary ciliary dyskinesia 23
|
|
Fibrosis of extraocular muscles, congenital, 2
|
|
Reis-Bucklers' corneal dystrophy
|
|
Fibrosis of extraocular muscles, congenital, 1
|
|
Meckel syndrome type 2
|
|
Meckel syndrome type 3
|
|
Cone-rod dystrophy 9
|
|
Meckel syndrome type 1
|
|
Meckel syndrome type 4
|
|
Meckel syndrome type 5
|
|
Leigh syndrome due to mitochondrial complex I deficiency
|
|
Trichorhinophalangeal dysplasia type I
|
|
Glanzmann's thrombasthenia
|
OMIM mapping confirmed by DO. [LS].
|
Cone-rod dystrophy 7
|
|
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
|
Multiple sulfatase deficiency
|
|
Lysinuric protein intolerance
|
Lysinuric protein intolerance (LPI) is a very rare inherited multisystem condition caused by distrubance in amino acid metabolism.
|
Corticosteroid-binding globulin deficiency
|
|
Synpolydactyly 1
|
|
Dysequilibrium syndrome
|
|
Combined oxidative phosphorylation deficiency 15
|
|
Corticosterone methyloxidase type 2 deficiency
|
|
Hereditary diffuse gastric cancer
|
|
Hyperlysinemia
|
An amino acid metabolic disorder that involves an abnormal increase of lysine in the blood.
|
Hypoproteinemia, hypercatabolic
|
|
Osteogenesis imperfecta type 5
|
Osteogenesis imperfecta type V is a moderate type of osteogenesis imperfecta (OI; see this term), a genetic disorder characterized by increased bone fragility, low bone mass and susceptibility to bone fractures with variable severity. OI type V is characterized by mild to moderate short stature, dislocation of the radial head, mineralized interosseous membranes, hyperplasic callus, white sclera and no dentinogenesis imperfecta (DI; see this term).
|
Haemorrhagic telangiectasia 2
|
|
Deafness, autosomal recessive 102
|
|
Atypical hemolytic-uremic syndrome 1
|
|
Atypical hemolytic-uremic syndrome 3
|
|
Johanson-Blizzard syndrome
|
An autosomal recessive disease that involves abnormal development of the pancreas, nose and scalp, with mental retardation, hearing loss and growth failure. It is inherited in an autosomal recessive manner.
|
Achromatopsia 4
|
|
Achromatopsia 5
|
|
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL
|
|
Achromatopsia 3
|
|
IL21R immunodeficiency
|
|
Keratitis, autosomal dominant
|
|
Charcot-Marie-Tooth disease, X-linked recessive, type 4
|
|
Charcot-Marie-Tooth disease, X-linked recessive, type 5
|
|
GRACILE syndrome
|
GRACILE syndrome is an inherited lethal mitochondrial disorder characterized by fetal growth restriction (GR), aminoaciduria (A), cholestasis (C), iron overload (I), lactacidosis (L), and early death (E).
|
Frontotemporal dementia, ubiquitin-positive
|
|
Nonaka myopathy
|
A myositis that is characterized by slowly progressive weakness and wasting of both distal and proximal muscles, most apparent in the muscles of the arms and legs that can occur in a sporadic or hereditary forms.
|
Testicular anomalies with or without congenital heart disease
|
|
X-linked lymphoproliferative syndrome 1
|
|
Lafora disease
|
OMIM mapping confirmed by DO. [SN].
|
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome
|
|
Kowarski syndrome
|
|
Lissencephaly 1
|
|
Hirschsprung disease, cardiac defects, and autonomic dysfunction
|
|
Lissencephaly 3
|
|
ADULT syndrome
|
An autosomal dominant disease that is characterized by light pigmentation with excessive freckling, sparse hair involving the scalp and axilla, lacrimal duct stenosis or atresia, onychodysplasia, hypodontia or early loss of permanent teeth, athelia or hypoplastic nipples, and breast hypoplasia, has_material_basis_in a mutation in TP63.
|
Lissencephaly 5
|
|
Lissencephaly 4
|
|
Meckel-Gruber syndrome
|
An autosomal recessive disease that is characterized by renal cystic dysplasia, occipital encephalocele, polydactyly (post axial), hepatic developmental defects, and pulmonary hypoplasia caused by dysfunction of primary cilia (ciliopathy) during early embryogenesis.
|
NEUROPATHY, HEREDITARY SENSORY, TYPE IE
|
|
NEUROPATHY, HEREDITARY SENSORY, TYPE ID
|
|
Paroxysmal nocturnal hemoglobinuria
|
NT MGI.
|
NEUROPATHY, HEREDITARY SENSORY, TYPE IF
|
|
Complement component 9 deficiency
|
NT MGI.
|
Niemann-Pick disease, type B
|
OMIM mapping confirmed by DO. [SN].
|
Niemann-Pick disease, type A
|
OMIM mapping confirmed by DO. [SN].
|
X-linked lymphoproliferative syndrome 2
|
|
Glycogen storage disease type X
|
|
Neutrophil immunodeficiency syndrome
|
Neutrophil immunodeficiency syndrome is a primary immunodeficiency characterized by neutrophilia with severe neutrophil dysfunction, leukocytosis, a predisposition to bacterial infections and poor wound healing, including an absence of pus in infected areas.
|
Tangier disease
|
OMIM mapping confirmed by DO. [LS].
|
Coffin-Lowry syndrome
|
OMIM mapping confirmed by DO. [SN].
|
Alpha-fetoprotein, hereditary persistence of
|
|
Holocarboxylase synthetase deficiency
|
A multiple carboxylase deficiency that involves a deficiency in holocarboxylase synthetase.
|
Auriculocondylar syndrome 2
|
|
Auriculocondylar syndrome 3
|
|
Auriculocondylar syndrome 1
|
|
Heterotaxy, visceral, 2, autosomal
|
|
Acute intermittent porphyria
|
|
2,4-Dienoyl-CoA reductase deficiency
|
|
Neural tube defect
|
|
Cone-rod dystrophy, X-linked 1
|
|
Ehlers-Danlos syndrome, hydroxylysine-deficient
|
|
Pierson syndrome
|
|
Palmoplantar keratoderma, mutilating, with periorificial keratotic plaques, X-linked
|
|
Pfeiffer syndrome
|
An acrocephalosyndactylia that has_material_basis_in mutations in the FGFR1 and FGFR2 gene which results_in premature fusion located_in skull.
|
Spastic paraplegia 72, autosomal recessive
|
|
Paroxysmal familial ventricular fibrillation
|
|
Familial hypercholesterolemia
|
A familial hyperlipidemia characterized by very high levels of low-density lipoprotein (LDL) and early cardiovascular disease.
|
Loeys-Dietz syndrome 1
|
|
Diastrophic dysplasia
|
An osteochondrodysplasia that has_material_basis_in abnormal cartilage development due to mutations in the SLC26A2 gene which results_in short limb dwarfism.
|
Endocrine-cerebroosteodysplasia
|
|
X-linked recessive hypophosphatemic rickets
|
|
Citrullinemia type II
|
Citrullinemia type 2 is a severe subtype of citrin deficiency (see this term) characterized clinically by adult onset (20 and 50 years of age), recurrent episodes of hyperammonemia and associated neuropsychiatric symptoms such as nocturnal delirium, confusion, restlessness, disorientation, drowsiness, memory loss, abnormal behavior (aggression, irritability, and hyperactivity), seizures, and coma.
|
Tricho-dento-osseous syndrome
|
|
Blood group, junior system
|
|
Thyrotoxic periodic paralysis
|
Thyrotoxic periodic paralysis (TPP) is a rare neurological disease characterized by recurrent episodes of paralysis and hypokalemia during a thyrotoxic state.
|
Surfactant metabolism dysfunction, pulmonary, 1
|
|
Surfactant metabolism dysfunction, pulmonary, 2
|
|
Mowat-Wilson syndrome
|
Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype, intellectual disability, epilepsy, Hirschsprung disease (HSCR; see this term) and variable congenital malformations.
|
Surfactant metabolism dysfunction, pulmonary, 4
|
|
Nephrotic syndrome, type 10
|
|
FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED
|
|
Cardiomyopathy dilated with woolly hair and keratoderma
|
|
Hidradenitis suppurativa, familial
|
|
Arthrogryposis, renal dysfunction, and cholestasis 2
|
|
LIPOPROTEIN(a) DEFICIENCY, CONGENITAL
|
|
Perrault syndrome 5
|
|
Mental retardation, X-linked 19
|
|
Perrault syndrome 2
|
|
Jensen syndrome
|
A syndrome that is characterized by sensorineural hearing loss with onset in infancy, followed in adolescence by progressive optic nerve atrophy with loss of vision and in adulthood by progressive dementia.
|
Capillary malformation without arteriovenous malformation
|
|
Pelger-Huët anomaly
|
|
Distal spinal muscular atrophy, X-linked 3
|
|
Werner syndrome
|
OMIM mapping confirmed by DO. [LS].
|
Cataract and cardiomyopathy
|
|
Fanconi anemia, complementation group C
|
|
Cardiomyopathy, dilated, 2b
|
|
Aarskog syndrome
|
A monogenic disease affects a person's height, muscles, skeleton, genitals, and appearance of the face.
|
Pseudoneonatal adrenoleukodystrophy
|
|
Dementia, familial Danish
|
|
Thanatophoric dysplasia type 1
|
Thanatophoric dysplasia type 1 (TD1) is a form of TD (see this term) characterized by short, bowed femurs, micromelia, narrow thorax, and brachydactyly.
|
Inflammatory skin and bowel disease, neonatal
|
|
Enamel-renal syndrome
|
|
Alkaptonuria
|
An amino acid metabolic disorder that involves phenylalanine and tyrosine metabolism with the accumulation of homogentisic acid, a toxic tyrosine byproduct.
|
Parkinsonism with spasticity, X-linked
|
|
Prostate cancer, hereditary, 12
|
|
Joubert syndrome 21
|
|
Joubert syndrome 20
|
|
Bile acid malabsorption, primary
|
|
Joubert syndrome 22
|
|
Multiple synostoses syndrome 2
|
|
Diaphyseal dysplasia
|
An osteosclerosis that has_material_basis_in mutations in the TGFB1 gene which results_in increased bone density located_in long bone.
|
Popliteal pterygium syndrome lethal type
|
|
Keutel syndrome
|
|
Deficiency of glycerate kinase
|
|
Progressive familial intrahepatic cholestasis 3
|
|
Progressive familial intrahepatic cholestasis 2
|
|
Pityriasis rubra pilaris
|
OMIM mapping confirmed by DO. [SN].
|
Ataxia with vitamin E deficiency
|
Ataxia with vitamin E deficiency (AVED) is a neurodegenerative disease belonging to the inherited cerebellar ataxias. It is mainly characterized by progressive spino-cerebellar ataxia, loss of proprioception, areflexia, and is associated with a marked deficiency in vitamin E.
|
Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance
|
|
Afibrinogenemia
|
|
Coloboma, uveal, with cleft lip and palate and mental retardation
|
|
Ventricular tachycardia
|
|
Cataract, microphthalmia and nystagmus
|
|
Pitt-Hopkins syndrome
|
Pitt-Hopkins syndrome (PHS) is characterized by the association of intellectual deficit, characteristic facial dysmorphism and problems of abnormal and irregular breathing.
|
Generalized epilepsy with febrile seizures plus 3
|
|
Segawa syndrome, autosomal recessive
|
|
Narcolepsy
|
A sleep disorder that involves an excessive urge to sleep at inappropriate times, such as while at work.
|
Methylmalonic aciduria, cblD type, variant 2
|
|
Foveal hypoplasia and anterior segment dysgenesis
|
|
Multiple pterygium syndrome Escobar type
|
|
PC-K6a
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6
|
|
Alopecia universalis congenita
|
|
Axenfeld anomaly
|
Axenfeld's anomaly is a bilateral disorder characterized by a prominent, anteriorly displaced Schwalbe's line (posterior embryotoxon) and peripheral iris strands which span the anterior chamber angle to attach to Schwalbe's line.
|
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation
|
|
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis
|
|
Pitt-Hopkins-like syndrome 2
|
|
Pitt-Hopkins-like syndrome 1
|
|
p phenotype
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
|
Lynch syndrome
|
Hereditary nonpolyposis colon cancer (HNPCC) is a cancer-predisposing condition characterized by the development of colorectal cancer (CRC), endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinay tract cancer) that are frequently diagnosed at an early age. Two types of HNPCC have been reported: Muir-Torre syndrome and non-polyposis Turcot syndrome (see these terms).
|
Vitelliform dystrophy
|
|
Neonatal adrenoleucodystrophy
|
|
Congenital short bowel syndrome, X-linked
|
|
Benign familial hematuria
|
|
C syndrome
|
C syndrome is a rare multiple congenital anomaly/intellectual disability syndrome characterized by trigonocephaly and metopic suture synostosis, dysmorphic facial features, short neck, skeletal anomalies, and variable intellectual disability.
|
Deficiency of galactokinase
|
|
ACTH deficiency
|
A reduced ability to secrete adrenocorticotropic hormone (ACTH), a hormone that stimulates the adrenal cortex to secrete of glucocorticoids such as cortisol.
|
Cole disease
|
|
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED
|
|
Myopia 23, autosomal recessive
|
|
Klippel-Feil syndrome 2, autosomal recessive
|
|
Microspherophakia
|
|
Progressive familial heart block type 1A
|
|
Progressive familial heart block type 1B
|
|
Stiff skin syndrome
|
|
Parkinson disease 8, autosomal dominant
|
|
Lenz microphthalmia syndrome
|
|
Spastic paraplegia 35
|
|
Myopathy, tubular aggregate, 2
|
|
Mental retardation, autosomal dominant 9
|
|
Familial dysautonomia
|
OMIM mapping confirmed by DO. [SN].
|
Dysplasminogenemia
|
|
Glycogen storage disease IXa2
|
|
Mental retardation, autosomal dominant 8
|
|
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome
|
|
Phosphoribosylpyrophosphate synthetase superactivity
|
Phosphoribosylpyrophosphate (PRPP) synthetase superactivity is an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, and comprising two forms: an early-onset severe form characterized by gout, urolithiasis, and neurodevelopmental anomalies, and a mild late-onset form with no neurologic involvement.
|
Marshall/Stickler syndrome
|
|
Schwartz Jampel syndrome type 1
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A8
|
|
Brachydactyly type B1
|
|
Grebe syndrome
|
|
Deafness, autosomal recessive 8
|
|
Deafness, autosomal recessive 9
|
|
Dysfibrinogenemia
|
Qualitatively abnormal fibrinogen.
|
Deafness, autosomal recessive 3
|
|
Saethre-Chotzen syndrome
|
An acrocephalosyndactylia that has_material_basis_in a genetic mutation in the TWIST1 gene which results_in premature fusion located_in skull.
|
Deafness, autosomal recessive 6
|
|
Deafness, autosomal recessive 7
|
|
Ataxia, sensory, autosomal dominant
|
|
Refsum disease, adult, 1
|
|
PROPERDIN DEFICIENCY, TYPE III
|
|
Porphyria, acute intermittent, nonerythroid variant
|
|
Carboxylesterase 1 deficiency
|
|
Hereditary lymphedema type I
|
|
Surfactant metabolism dysfunction, pulmonary, 3
|
|
Spinocerebellar ataxia, autosomal recessive 15
|
|
Bone fragility with contractures, arterial rupture, and deafness
|
|
Cleidocranial dysplasia, forme fruste, with brachydactyly
|
|
Spinocerebellar ataxia, autosomal recessive 12
|
|
Spinocerebellar ataxia, autosomal recessive 11
|
|
Spinocerebellar ataxia, autosomal recessive 10
|
|
Congenital heart disease, multiple types, 2
|
|
Spastic paraplegia 44, autosomal recessive
|
|
Spastic ataxia 5, autosomal recessive
|
|
Mutilating keratoderma
|
|
Myasthenic syndrome, slow-channel congenital
|
|
Mucopolysaccharidosis, MPS-I-S
|
|
Pituitary dependent hypercortisolism
|
|
Myofibrillar myopathy, filamin C-related
|
|
Pulmonary alveolar microlithiasis
|
OMIM mapping confirmed by DO. [SN].
|
Spinocerebellar ataxia 5
|
|
Floating-Harbor syndrome
|
Floating-Harbor syndrome is a genetic developmental disorder characterized by facial dysmorphism, short stature with delayed bone age, and expressive language delay.
|
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm
|
|
Warburg micro syndrome 1
|
|
Warburg micro syndrome 3
|
|
Warburg micro syndrome 2
|
|
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V
|
|
Werdnig-Hoffmann disease
|
OMIM mapping confirmed by DO. [SN].
|
Hermansky-Pudlak syndrome 1
|
|
Osteitis deformans
|
A bone formation disease that has_material_basis_in hyperactive osteoclast which results_in abnormal osteoblast bone formation located_in skull, located_in pelvis, located_in vertebral column, located_in set of limbs.
|
Osler hemorrhagic telangiectasia syndrome
|
An autosomal dominant disease characterized by the presence of multiple arteriovenous malformations that lack intervening capillaries and result in direct connections between arteries and veins.
|
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3
|
|
Hereditary diffuse leukoencephalopathy with spheroids
|
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia is a rare autosomal dominant disease characterized by a complex phenotype including progressive dementia, apraxia, apathy, impaired balance, parkinsonism, spasticity and epilepsy.
|
Charcot-Marie-Tooth disease, recessive intermediate B
|
|
Wieacker syndrome
|
|
Parkinson disease 14
|
|
Double outlet right ventricle
|
OMIM mapping confirmed by DO. [SN].
|
Parkinson disease 15
|
|
Permanent neonatal diabetes mellitus
|
Permanent neonatal diabetes mellitus (PNDM) is a monogenic form of neonatal diabetes (NDM, see this term) characterized by persistent hyperglycemia within the first 12 months of life in general, requiring continuous insulin treatment.
|
Purine-nucleoside phosphorylase deficiency
|
A combined T cell and B cell immunodeficiency that is a rare autosomal recessive metabolic disorder caused by a mutaion in the PNP gene and characterized mainly by decreased T-cell function.
|
Osteopetrosis autosomal dominant type 1
|
|
Parietal foramina 2
|
|
Kabuki make-up syndrome
|
Kabuki syndrome (KS) is a multiple congenital anomaly syndrome characterized by typical facial features, skeletal anomalies, mild to moderate intellectual disability and postnatal growth deficiency.
|
Gm2-gangliosidosis, variant b1
|
|
Severe congenital neutropenia X-linked
|
|
Homocystinuria, cblD type, variant 1
|
|
Tetralogy of Fallot
|
OMIM mapping confirmed by DO. [LS].
|
Neonatal intrahepatic cholestasis caused by citrin deficiency
|
Neonatal intrahepatic cholestasis due to citrin deficiency is a mild subtype of citrin deficiency (see this term) characterized clinically by low birth weight, failure to thrive, growth retardation, transient intrahepatic cholestasis, multiple aminoacidemia, galactosemia, hypoproteinemia, hepatomegaly, decreased coagulation factors, hemolytic anemia, variable but mostly mild liver dysfunction, and hypoglycemia.
|
Indifference to pain, congenital, autosomal recessive
|
|
Congenital stationary night blindness, autosomal dominant 1
|
|
Cohen syndrome
|
Cohen syndrome (CS) is a rare genetic developmental disorder characterized by microcephaly, characteristic facial features, hypotonia, non-progressive intellectual deficit, myopia and retinal dystrophy, neutropenia and truncal obesity.
|
Oligodontia-colorectal cancer syndrome
|
|
Atrial fibrillation
|
A heart conduction disease that is characterized by uncoordinated electrical activity in the heart's upper chambers (the atria), which causes the heartbeat to become fast and irregular and has symptoms palpitations, weakness, fatigue, lightheadedness, dizziness, confusion, shortness of breath and chest pain.
|
Filippi syndrome
|
|
Retinitis pigmentosa
|
A retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss.
|
Lethal congenital contractural syndrome 3
|
|
Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement
|
|
Acrodysostosis 2, with or without hormone resistance
|
|
Retinitis pigmentosa 17
|
|
Juvenile nephropathic cystinosis
|
|
Myopathy with lactic acidosis, hereditary
|
|
Primrose syndrome
|
|
Complement component 6 deficiency
|
NT MGI.
|
Chronic granulomatous disease, X-linked
|
|
Antithrombin III deficiency
|
An inherited blood coagulation disease characterized by the tendency to form clots in the veins.
|
Perrault syndrome 4
|
|
Charcot-Marie-Tooth disease, dominant intermediate b, with neutropenia
|
|
Inosine triphosphatase deficiency
|
|
Marshall-Smith syndrome
|
A syndrome that is characterized by advanced bone age, failure to thrive, respiratory problems, dysmorphic facial features, and variable mental retardation.
|
Junctional epidermolysis bullosa gravis of Herlitz
|
|
Loeys-Dietz syndrome
|
|
Familial febrile seizures 8
|
|
Congenital heart defects, multiple types, 4
|
|
Congenital erythropoietic porphyria
|
|
Corneal dystrophy, fuchs endothelial, 8
|
|
Brittle cornea syndrome 2
|
|
Rotor syndrome
|
Rotor syndrome (RT) is a benign, inherited liver disorder characterized by chronic, predominantly conjugated, nonhemolytic hyperbilirubinemia with normal liver histology.
|
Corneal dystrophy, fuchs endothelial, 4
|
|
Spherocytosis type 1
|
|
Corneal dystrophy, fuchs endothelial, 6
|
|
Spastic paraplegia 72, autosomal dominant
|
|
Spherocytosis type 5
|
|
Oral-facial-digital syndrome
|
|
Ovarioleukodystrophy
|
|
Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
|
|
Cardiomyopathy, dilated, 1nn
|
|
Pyridoxal 5'-phosphate-dependent epilepsy
|
|
Hemoglobinopathy
|
|
Acrocallosal syndrome, Schinzel type
|
|
Secondary hypothyroidism
|
A type of hypothyroidism that results from a defect in thyroid-stimulating hormone secretion.
|
Craniometaphyseal dysplasia, autosomal dominant
|
|
Gray platelet syndrome
|
Gray platelet syndrome (GPS) is a rare inherited bleeding disorder characterized by macrothrombocytopenia, myelofibrosis, splenomegaly and typical gray appearance of platelets on Wright stained peripheral blood smear.
|
Mast syndrome
|
A hereditary spastic paraplegia associated with dementia.
|
Amish infantile epilepsy syndrome
|
|
Benign scapuloperoneal muscular dystrophy with cardiomyopathy
|
|
Meacham syndrome
|
Meacham syndrome is a multiple malformation syndrome characterized by congenital diaphragmatic abnormalities, genital defects and cardiac malformations.
|
Pontocerebellar hypoplasia, type 10
|
NT MGI.
|
3-Methylglutaconic aciduria type 3
|
|
Growth hormone deficiency with pituitary anomalies
|
|
Stormorken syndrome
|
|
Hypomagnesemia 4, renal
|
|
Opitz-Frias syndrome
|
|
congenital neutropenia
|
A form of neutropenia with congenital onset.
|
Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia
|
|
Schneckenbecken dysplasia
|
|
Acromicric dysplasia
|
Acromicric dysplasia is a rare bone dysplasia characterized by short stature, short hands and feet, mild facial dysmorphism, and characteristic X-ray abnormalities of the hands.
|
Retinal degeneration, autosomal recessive, clumped pigment type
|
|
Cardio-facio-cutaneous syndrome
|
A syndrome characterized by unusually sparse, brittle, curly hair, macrocephaly, a prominent forehead and bi-temporal narrowing, intellectual disability, failure to thrive, congenital heart defects, short stature and skin abnormalities; it is caused by mutation in the BRAF, MAP2K1, MAP2kK2 and KRAS genes.
|
Mitochondrial DNA depletion syndrome 11
|
|
Kallmann syndrome 1
|
|
Kallmann syndrome 2
|
|
Nephrolithiasis/osteoporosis, hypophosphatemic, 1
|
|
Kallmann syndrome 4
|
|
Kallmann syndrome 5
|
|
Kallmann syndrome 6
|
|
Yunis Varon syndrome
|
|
Early infantile epileptic encephalopathy 18
|
|
Early infantile epileptic encephalopathy 13
|
|
Tremor, hereditary essential, 4
|
|
Hyperchlorhidrosis, isolated
|
|
Early infantile epileptic encephalopathy 10
|
|
Early infantile epileptic encephalopathy 17
|
|
Early infantile epileptic encephalopathy 16
|
|
Early infantile epileptic encephalopathy 14
|
|
FLNB-Related Disorders
|
|
Syndactyly type 5
|
Syndactyly type 5 (SD5) is a very rare congenital limb malformation characterized by postaxial syndactyly of hands and feet, associated with metacarpal and metatarsal fusion of fourth and fifth digits.
|
Pyruvate dehydrogenase lipoic acid synthetase deficiency
|
|
Homocystinuria, pyridoxine-nonresponsive
|
|
Terminal osseous dysplasia
|
|
Friedreich's ataxia
|
Xref MGI.
|
MEN2 phenotype: Unknown:Multiple endocrine neoplasia, type 2a
|
|
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
|
Nasu-Hakola disease (NHD), also referred to as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), is a rare inherited leukodystrophy characterized by progressive presenile dementia associated with recurrent bone fractures due to polycystic osseous lesions of the lower and upper extremities.
|
Dystonia 12
|
Rapid-onset dystonia-parkinsonism (RDP) is a very rare movement disorder, characterized by the abrupt onset of parkinsonism and dystonia, often triggered by physical or psychological stress.
|
Dystonia 10
|
|
Dystonia 16
|
Dystonia 16 (DYT16) is a very rare and newly discovered movement disorder which is characterized by early-onset progressive limb dystonia, laryngeal and oromandibular dystonia, and parkinsonism.
|
Ulna and fibula absence of with severe limb deficiency
|
|
Cowden syndrome
|
|
Dystonia 18
|
Paroxysmal exertion-induced dyskinesia (PED) is a form of paroxysmal dyskinesia (see this term), characterized by painless attacks of dystonia of the extremities triggered by prolonged physical activities.
|
Amyotrophic lateral sclerosis 6, autosomal recessive
|
|
Growth hormone insensitivity with immunodeficiency
|
|
Retinitis pigmentosa 19
|
|
Mulibrey nanism syndrome
|
|
Ohdo syndrome, X-linked
|
|
Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency
|
|
Epilepsy, progressive myoclonic 2b
|
|
Hypothyroidism, congenital, nongoitrous, 1
|
|
Hypothyroidism, congenital, nongoitrous, 5
|
|
Hypothyroidism, congenital, nongoitrous, 6
|
|
Primary hyperoxaluria, type I
|
|
Retinitis pigmentosa 60
|
|
Homocysteinemia due to MTHFR deficiency
|
|
Epidermolysis bullosa simplex, autosomal recessive 2
|
|
Beta thalassemia intermedia
|
Beta-thalassemia (BT) intermedia is a form of BT (see this term) characterized by mild to moderate anemia which does not or only occasionally requires transfusion.
|
Nephrotic syndrome, idiopathic, steroid-resistant
|
|
Townes-Brocks-branchiootorenal-like syndrome
|
|
SeSAME syndrome
|
|
Pustular psoriasis, generalized
|
|
Deficiency of pyrroline-5-carboxylate reductase
|
|
Immunodeficiency due to ficolin 3 deficiency
|
|
Corneal dystrophy Fuchs endothelial 1
|
|
Deafness, autosomal recessive 18b
|
|
Sarcosine dehydrogenase deficiency
|
|
Retinitis pigmentosa 14
|
|
ZNF711-Related X-linked Mental Retardation
|
|
Congenital disorder of glycosylation type 1s
|
|
Vitreoretinochoroidopathy dominant
|
|
Odontotrichomelic syndrome
|
|
Congenital disorder of glycosylation type 1L
|
|
Limb-girdle muscular dystrophy, type 1F
|
|
Limb-girdle muscular dystrophy, type 1E
|
|
Spastic ataxia Charlevoix-Saguenay type
|
|
Resting heart rate
|
|
Epidermolysis bullosa, junctional, localisata variant
|
|
Trimethylaminuria
|
Increased concentration of trimethylamine in the urine.
|
Erythrokeratodermia with ataxia
|
Spinocerebellar ataxia type 34 (SCA34) is a subtype of autosomal dominant cerebellar ataxia type 1 (ADCA type 1; see this term), characterized by papulosquamous, ichthyosiform plaques on the limbs appearing shortly after birth and later manifestations including progressive ataxia, dysarthria, nystagmus and decreased reflexes.
|
Factor v and factor viii, combined deficiency of, 2
|
|
Severe X-linked myotubular myopathy
|
|
Delta-0-thalassemia
|
|
Breast cancer, early-onset
|
|
Branched-chain ketoacid dehydrogenase kinase deficiency
|
|
Thrombophilia due to activated protein C resistance
|
|
Juvenile GM>1< gangliosidosis
|
GM1 gangliosidosis type 2 is a clinically variable, infancy or childhood-onset form of GM1 gangliosidosis (see this term) characterized by normal early development and psychomotor regression between seven months and three years of age.
|
Atrioventricular septal defect, partial, with heterotaxy syndrome
|
|
Meckel syndrome, type 6
|
|
L-ferritin deficiency
|
|
Parkinson disease 19, juvenile-onset
|
|
Histidinemia
|
A histidine metabolism disease that involves a deficiency of the enzyme histidase.
|
Infantile liver failure syndrome 1
|
|
Spastic paraplegia 26
|
|
Infantile liver failure syndrome 2
|
|
Neurodegeneration with brain iron accumulation 2b
|
|
Dystransthyretinemic euthyroidal hyperthyroxinemia
|
|
NIEMANN-PICK DISEASE, TYPE C1, ADULT FORM
|
|
Lamellar ichthyosis
|
OMIM mapping confirmed by DO. [SN].
|
Sensorineural deafness with mild renal dysfunction
|
|
Nephrolithiasis/osteoporosis, hypophosphatemic, 2
|
|
Hypomyelination, global cerebral
|
|
Niemann-Pick disease type C2
|
|
Niemann-Pick disease type C1
|
|
Medium-chain acyl-coenzyme A dehydrogenase deficiency
|
|
Lowe syndrome
|
|
Rhizomelic chondrodysplasia punctata type 1
|
|
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset
|
|
Retinitis Pigmentosa 23
|
|
Reticular dysgenesis
|
A severe combined immunodeficiency that is the most severe form of SCID and is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. It is characterized by congenital agranulocytosis, lymphopenia, and lymphoid and thymic hypoplasia with absent cellular and humoral immunity functions.
|
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency
|
|
Hypogonadotropic hypogonadism 13 with or without anosmia
|
|
Cholestanol storage disease
|
|
Ehlers-Danlos syndrome, type 7B
|
|
Ehlers-Danlos syndrome, musculocontractural type 2
|
|
Vitreoretinopathy with phalangeal epiphyseal dysplasia
|
|
Myopathy, actin, congenital, with excess of thin myofilaments
|
|
Fleck retina, familial benign
|
|
Multiple congenital anomalies-hypotonia-seizures syndrome
|
|
Rett syndrome, congenital variant
|
|
Spinocerebellar ataxia, X-linked 1
|
|
Van Maldergem syndrome 2
|
|
X-linked familial exudative vitreoretinopathy
|
|
Arginase deficiency
|
|
Robinow syndrome
|
A syndrome characterized by mild to moderate short stature due to growth delays after birth, distinctive craniofacial abnormalities, skeletal malformations and genital abnormalities.
|
Acromesomelic dysplasia Maroteaux type
|
An acromesomelic dysplasia that has_material_basis_in mutation in NPR-B receptor which results_in severe dwarfism, abnormalities of the located_in vertebral column and shortening of middle and distal segments in the located_in limb.
|
Bone marrow failure syndrome 2
|
|
Brachydactyly type E2
|
|
Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 1
|
|
Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2
|
|
Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 3
|
|
Supravalvar aortic stenosis
|
a narrowing, diffuse constriction or obstruction of the ascending aorta located just distal to the aortic valve at the aortic root
|
Prolonged electroretinal response suppression
|
|
Hepatic lipase deficiency
|
|
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity
|
|
Orofaciodigital syndrome 6
|
|
Orofaciodigital syndrome 5
|
|
Factor X deficiency
|
|
Metacarpal 4-5 fusion
|
|
Delayed puberty
|
Passing the age when puberty normally occurs with no physical or hormonal signs of the onset of puberty.
|
mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
|
|
Leukoencephalopathy with ataxia
|
|
Hereditary Paragangliomas and Pheochromocytomas
|
|
Distichiasis-lymphedema syndrome
|
|
Townes syndrome
|
|
Cowden disease 3
|
|
Neu-Laxova syndrome
|
Neu-Laxova syndrome (NLS) is a rare, multiple malformation syndrome characterised by severe intrauterine growth retardation (IUGR), severe microcephaly with a sloping forehead, severe ichthyosis (collodion baby type), and facial dysmorphism.
|
Winchester syndrome
|
|
Combined immunodeficiency, X-linked
|
|
Familial colorectal cancer
|
|
Unverricht-Lundborg syndrome
|
OMIM mapping confirmed by DO. [LS].
|
X-linked rolandic epilepsy with mental retardation and speech dyspraxia
|
|
Band-like calcification with simplified gyration and polymicrogyria
|
No OMIM mapping, confirmed by DO. [SN].
|
Spastic paraplegia 55, autosomal recessive
|
|
Autosomal recessive congenital ichthyosis 9
|
|
Xeroderma pigmentosum, complementation group b
|
Xeroderma pigmentosum complementation group B (XPB) is an extremely rare subtype of xeroderma pigmentosum (XP; see this term), a rare photodermatosis predisposing to skin cancers.
|
Eichsfeld type congenital muscular dystrophy
|
|
Verheij syndrome
|
|
Rapp-Hodgkin ectodermal dysplasia syndrome
|
|
Familial porphyria cutanea tarda
|
|
Renal tubular acidosis, distal, with normal red cell morphology
|
|
Non-syndromic genetic deafness
|
|
Hypercarotenemia and vitamin a deficiency, autosomal dominant
|
|
Allan-Herndon-Dudley syndrome
|
An X-linked disease that is caused by mutation in the gene encoding the monocarboxylate transporter-8 which alters the structure and function of the SLC16A2 protein which is then unable to transport the thyroid triiodothyronine (T3) hormone into nerve cells of the developing brain affecting normal brain development resulting in intellectual disability and problems with movement.
|
Familial hypertrophic cardiomyopathy 20
|
|
Efavirenz response
|
|
Renal dysplasia
|
Renal dysplasia is a form of renal malformation in which the kidney(s) are present but their development is abnormal and incomplete. Renal dysplasia can be unilateral or bilateral (see these terms), segmental, and of variable severity, with renal aplasia corresponding to extreme dysplasia.
|
Syndactyly type 9
|
Mesoaxial synostotic syndactyly (MSSD) with phalangeal reduction is a novel and distinct form of non-syndromic syndactyly including complete syndactyly of the 3rd and 4th fingers with synostoses of the corresponding metacarpals and associated single phalanges, syndactyly of the 2nd and 3rd toes and 5th finger clinodactyly.
|
Adrenoleukodystrophy
|
A leukodystrophy that disrupts the breakdown of very-long-chain fatty acids resulting in progressive brain damage, failure of the adrenal glands and eventually death.
|
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant
|
|
Tay-sachs disease, juvenile
|
|
Myocardial infarction 1
|
|
Glycogen storage disease IIIa
|
|
Distal hereditary motor neuronopathy type 2A
|
|
Distal hereditary motor neuronopathy type 2C
|
|
Distal hereditary motor neuronopathy type 2B
|
|
Progressive familial intrahepatic cholestasis 4
|
|
Stargardt disease 1
|
An age related macular degeneration that is characterized by progressive vision loss usually to the point of legal blindness.
|
Pyruvate dehydrogenase E3-binding protein deficiency
|
Pyruvate dehydrogenase E3-binding protein deficiency is a rare mild form of pyruvate dehydrogenase deficiency (PDHD, see this term) characterized by variable lactic acidosis and neurological dysfunction.
|
Advanced sleep phase syndrome, familial, 2
|
|
Congenital disorder of glycosylation type 2B
|
|
Congenital disorder of glycosylation type 2C
|
|
Sick sinus syndrome 1, autosomal recessive
|
|
Arterial tortuosity syndrome
|
A connective tissue disease that is characterized by elongation and generalized tortuosity of the major arteries including the aorta.
|
Nonsyndromic Deafness
|
An auditory system disease that is associated with permanent hearing loss caused by damage to structures in the inner ear and/or the middle ear, which is not associated with other signs and symptoms.
|
Hereditary factor IX deficiency disease
|
|
Congenital disorder of glycosylation type 2J
|
|
Congenital disorder of glycosylation type 2L
|
|
Distal myopathy Markesbery-Griggs type
|
|
Bronchiectasis
|
A bronchial disease that is a chronic inflammatory condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls resulting from damage to the airway wall leading to the formation of small sacs on the bronchial wall and impairment of cilia mobility in the lung. Inflammation of the bronchial wall increases mucus secretion which serves as a breeding ground for bacteria. Bronchiectasis is caused by repeated respiratory infections, immune deficiency disorders, hereditary disorders (cystic fibrosis or primary ciliary dyskinesia), mechanical factors (inhaled object or a lung tumor) or inhaling toxic substances.
|
Juvenile polyposis syndrome
|
An autosomal dominant disease that is characterized by predisposition to hamartomatous benign polyps in the gastrointestinal tract, specifically in the stomach, small intestine, colon, and rectum.
|
Papillon-Lefèvre syndrome
|
|
Alpha-fetoprotein deficiency
|
|
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A14
|
|
CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED
|
|
Parathyroid carcinoma
|
An endocrine gland cancer located_in the parathyroid glands located in the neck.
|
Congenital disorder of glycosylation type 2k
|
|
Brown-vialetto-van laere syndrome 2
|
|
Spinal muscular atrophy
|
A motor neuron disease that is a degenerative neuromuscular disease characterized by motor neuron degeration.
|
Myopathy, congenital, with excess of muscle spindles
|
|
Microcephaly, epilepsy, and diabetes syndrome
|
|
Peters plus syndrome
|
Peters plus syndrome is an autosomal recessively inherited syndromic developmental defect of the eye (see this term) characterized by a variable phenotype including Peters anomaly (see this term) and other anterior chamber eye anomalies, short limbs, hand abnormalities (i.e. broad distal extremities), characteristic facial features (upper lip with cupid bow, short palpebral fissures), cleft lip/palate and mild to severe developmental delay/intellectual disability. Other associated abnormalities reported in some patients include congenital heart defects (i.e. hypoplastic left heart, absence of right pulmonary vein, bicuspid pulmonary valve), genitourinary anomalies (hydronephrosis, renal hypoplasia, renal and ureteral duplication, multicystic dysplastic kidneys, glomerulocystic kidneys), and congenital hypothyroidism.
|
Cerebellar ataxia and hypogonadotropic hypogonadism
|
|
Hypermethioninemia due to adenosine kinase deficiency
|
|
NSDHL-Related Disorders
|
|
Ulnar-mammary syndrome
|
|
Ocular albinism, type I
|
|
Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5
|
|
Coproporphyria
|
|
Mental retardation, autosomal recessive 18
|
|
Hypotrichosis simplex
|
Hypotrichosis simplex (HS) or hereditary hypotrichosis simplex (HHS) is characterized by reduced pilosity over the scalp and body (with sparse, thin, and short hair) in the absence of other anomalies.
|
Schimke immunoosseous dysplasia
|
Schimke immuno-osseous dysplasia (SIOD) is a multisystem disorder characterized by spondyloepiphyseal dysplasia and disproportionate short stature, facial dysmorphism, T-cell immunodeficiency, and glomerulonephritis with nephrotic syndrome.
|
Vitamin k-dependent clotting factors, combined deficiency of, 1
|
|
Spastic paraplegia 63, autosomal recessive
|
|
Lymphedema, hereditary, ic
|
|
Lymphedema, hereditary, id
|
|
Deficiency of iodide peroxidase
|
|
Glycosylphosphatidylinositol deficiency
|
|
Myopathy, distal, 4
|
|
Insulin-dependent diabetes mellitus secretory diarrhea syndrome
|
|
Vitamin k-dependent clotting factors, combined deficiency of, 2
|
|
Mental retardation, autosomal recessive 27
|
|
Spastic paraplegia 31, autosomal dominant
|
|
Zunich neuroectodermal syndrome
|
|
Conotruncal heart malformations
|
|
Nemaline myopathy 2, autosomal recessive
|
|
Myoclonus, familial cortical
|
|
Erythropoietic protoporphyria
|
An acute porphyria characterized by a deficiency in the enzyme ferrochelatase, leading to abnormally high levels of protoporphyrin in the tissue.
|
Leukocyte adhesion deficiency type 1
|
|
Congenital lactase deficiency
|
Congenital lactase deficiency is a rare severe gastrointestinal disorder in newborns primarily reported in Finland and characterized clinically by watery diarrhea on feeding with breast-milk or lactose-containing formula.
|
3-methylglutaconic aciduria type V
|
|
Beckwith-Wiedemann syndrome
|
A syndrome characterized by overgrowth (macrosomia), an increased risk of childhood cancer and congenital malformations.
|
Congenital myotonia, autosomal recessive form
|
|
Aplasia cutis congenita
|
A developmental defect resulting in the congenital absence of skin in multiple or solitary non-inflammatory, well-demarcated, oval or circular ulcers with a diameter of about 1 to 2 cm. Aplasia cutis congenita most commonly occurs on the scalp, but may present in the face, trunk, or limbs.
|
Van Maldergem Wetzburger Verloes syndrome
|
|
X-linked mental retardation, with or without seizures, ARX-related
|
|
Hereditary myopathy with early respiratory failure
|
|
Deafness, autosomal recessive 91
|
|
Sotos' syndrome
|
An autosomal recessive disease that occurs rarely and is characterized by excessive physical growth during the first 2 to 3 years of life.
|
Severe congenital neutropenia 6, autosomal recessive
|
|
Dyggve-Melchior-Clausen syndrome
|
|
Congenital disorder of glycosylation type 1Q
|
|
Cardiac arrest
|
A congestive heart failure characterized by a sudden stop in effective blood circulation due to the failure of the heart to contract effectively or at all.
|
Baraitser-Winter Syndrome 2
|
|
Congenital disorder of glycosylation type 1P
|
|
Three M syndrome 2
|
|
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5
|
|
Nephronophthisis 15
|
|
Hypokalemic periodic paralysis, type 2
|
|
Migraine, familial basilar
|
|
Howel-Evans syndrome
|
|
Breast-ovarian cancer, familial 2
|
|
X-linked myopathy with postural muscle atrophy
|
|
Myoclonic dystonia
|
Myoclonus-dystonia syndrome (MDS) is a rare movement disorder characterized by mild to moderate dystonia along with 'lightning-like' myoclonic jerks.
|
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1
|
|
Epilepsy, X-linked, with variable learning disabilities and behavior disorders
|
|
Cataract, membranous
|
|
Acrocapitofemoral dysplasia
|
OMIM mapping confirmed by DO. [SN].
|
Optic atrophy and cataract, autosomal dominant
|
|
Senior-Loken syndrome 7
|
|
Sandhoff disease, adult type
|
|
Senior-Loken syndrome 4
|
|
Congenital disorder of glycosylation type 1H
|
|
Gaucher disease, perinatal lethal
|
|
Malformation of the heart
|
|
Senior-Loken syndrome 5
|
|
Hypercholanemia, familial
|
|
Myasthenic syndrome, congenital, with tubular aggregates 2
|
|
Hypogonadotropic hypogonadism
|
No OMIM mapping, confirmed by DO. [LS].
|
Dilated cardiomyopathy 1C
|
|
Renal cell carcinoma, papillary, 1
|
|
MYH-associated polyposis
|
|
Cataract, juvenile, with microcornea and glucosuria
|
|
Leri Weill dyschondrosteosis
|
|
Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease
|
|
Infantile nephronophthisis
|
|
Glycogen storage disease type 13
|
|
D-2-hydroxyglutaric aciduria 2
|
|
Caspase-8 deficiency
|
|
Progressive myoclonus epilepsy with ataxia
|
|
Congenital disorder of glycosylation type 1N
|
|
Alexander's disease
|
A leukodystrophy that is characterized by the destruction of white matter and the formation of Rosenthal fibers consisting of abnormal clumps of protein that accumulate in astrocytes.
|
Optic Atrophy Type 1
|
|
Rhabdoid tumor predisposition syndrome 2
|
|
Lethal arthrogryposis with anterior horn cell disease
|
|
Mucopolysaccharidosis type VI
|
|
Deafness, autosomal dominant 11
|
|
Finnish congenital nephrotic syndrome
|
|
Tatton-Brown-rahman syndrome
|
|
Dentinogenesis imperfecta - Shield's type II
|
|
Glutaric acidemia IIA
|
|
Uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
|
Glutaric acidemia IIC
|
|
Glutaric acidemia IIB
|
|
Syndactyly type 3
|
Syndactyly type 3 (SD3) is a rare congenital distal limb malformation characterized by complete and bilateral syndactyly between the 4th and 5th fingers.
|
Phosphoglycerate kinase 1 deficiency
|
|
Multiple gastrointestinal atresias
|
|
MUCOPOLYSACCHARIDOSIS, TYPE VI, INTERMEDIATE
|
|
Dilated cardiomyopathy 1M
|
|
Bile acid synthesis defect, congenital, 1
|
|
Anaphylotoxin inactivator deficiency
|
|
Bile acid synthesis defect, congenital, 2
|
|
Acromelic frontonasal dysostosis
|
|
Dilated cardiomyopathy 1N
|
|
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency
|
|
COACH syndrome
|
Joubert syndrome with hepatic defect is a very rare subtype of Joubert syndrome and related disorders (JSRD, see this term) characterized by the neurological features of JS associated with congenital hepatic fibrosis (CHF).
|
Hypochromic microcytic anemia with iron overload
|
|
Congenital disorder of glycosylation type 1F
|
|
Short rib polydactyly syndrome 5
|
|
Adult junctional epidermolysis bullosa
|
|
Short rib polydactyly syndrome 6
|
|
Ceroid lipofuscinosis, neuronal, 2
|
|
Enhanced s-cone syndrome
|
Goldmann-Favre syndrome (GFS) is a vitreoretinal dystrophy characterized by early onset of night blindness, reduced bilateral visual acuity, and typical fundus findings (progressive pigmentary degenerative changes, macular edema, retinoschisis).
|
Deafness, autosomal recessive 84b
|
|
Variegate porphyria
|
|
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII
|
|
X-linked hydrocephalus syndrome
|
|
Multiple exostoses type 2
|
|
Acquired long QT syndrome
|
A form of long QT syndrome in which malfunction of the cardiac ion channels is caused by drugs or metabolic abnormalities. Common genetic variation may influence susceptibility to acquired long QT syndrome.
|
Hypomagnesemia 5, renal, with ocular involvement
|
|
Obesity
|
An eating-related disorder in which excess body fat has accumulated to such an extent that health may be negatively affected. It is commonly defined as a body mass index (weight divided by height squared) of 30 kg/m2 or higher.|A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
|
Cholestasis, intrahepatic, of pregnancy 3
|
|
Gm2-gangliosidosis, juvenile
|
|
Cytochrome-c oxidase deficiency
|
|
Van der Woude syndrome
|
A syndrome characterized by the combination of lower lip pits, cleft lip with or without cleft palate and cleft palate alone.
|
Phosphohydroxylysinuria
|
|
Thyroid cancer, follicular
|
|
Glycogen storage disease type 1A
|
Glycogenosis due to glucose-6-phosphatase deficiency (G6P) type a, or glycogen storage disease (GSD) type 1a, is a type of glycogenosis due to G6P deficiency (see this term).
|
Enterokinase deficiency
|
|
Cornelia de Lange syndrome 1
|
|
Interstitial nephritis, karyomegalic
|
|
Aplastic anemia
|
An anemia that is characterized by a deficiency of red blood cells, white blood cells and platelets produced by bone marrow.
|
Coenzyme Q10 deficiency, primary, 6
|
|
Primary pulmonary hypertension 3
|
|
Coenzyme Q10 deficiency, primary, 5
|
|
Coenzyme Q10 deficiency, primary, 2
|
|
Coenzyme Q10 deficiency, primary, 3
|
|
Erythrocyte amp deaminase deficiency
|
|
Sudden infant death syndrome
|
Unexpected death in infancy which remains unexplained following autopsy, review of the medical history, and investigation of the death circumstances and death scene.
|
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation
|
|
Factor VII deficiency
|
|
Pseudo-Hurler polydystrophy
|
Mucolipidosis III alpha/beta (MLIII alpha/beta) is a lysosomal disorder characterized by progressive slowing of the growth rate from early childhood, stiffness and pain in joints, gradual coarsening of facial features, moderate developmental delay and mild intellectual disability in most patients.
|
Galactosialidosis, early infantile
|
|
Epidermolysis bullosa with pyloric atresia
|
|
Autosomal dominant CD11C+/CD1C+ dendritic cell deficiency
|
|
Bone marrow failure, familial
|
|
Spinal muscular atrophy, lower extremity predominant 2, autosomal dominant
|
|
Postaxial polydactyly type A6
|
|
Pyloric stenosis, infantile hypertrophic, 5
|
|
Cerebellar ataxia, deafness, and narcolepsy
|
|
Congenital disorder of glycosylation type 1v
|
|
Congenital muscular dystrophy
|
A muscular dystrophy that is an autosomal recessive disorder present at birth, which may result in contractures, scoliosis, respiratory and swallowing difficulties, and foot deformities.
|
Blood group, gerbich system
|
|
Cataract, congenital nuclear, autosomal recessive 2
|
|
Cataract, congenital nuclear, autosomal recessive 3
|
|
Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities
|
|
Facioscapulohumeral muscular dystrophy 2
|
|
Ceroid lipofuscinosis neuronal 10
|
|
Dursun syndrome
|
|
Distal hereditary motor neuronopathy type 5B
|
|
Severe combined immunodeficiency, atypical
|
|
Cone monochromatism
|
|
Sitosterolemia
|
|
Posterior polar cataract type 2
|
|
Retinitis pigmentosa 69
|
|
Retinitis pigmentosa 68
|
|
Retinitis pigmentosa 67
|
|
Retinitis pigmentosa 66
|
|
Retinitis pigmentosa 64
|
|
Retinitis pigmentosa 62
|
|
Carpenter syndrome 2
|
|
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
|
|
Aortic aneurysm, familial thoracic 4
|
|
Glucose-6-phosphate transport defect
|
|
Li-Fraumeni syndrome 1
|
|
Haim-Munk syndrome
|
|
Knobloch syndrome 1
|
|
Diabetes mellitus, insulin-dependent, 20
|
|
Tooth agenesis, selective, 4
|
|
Iodotyrosine deiodination defect
|
|
Carbohydrate-deficient glycoprotein syndrome type I
|
|
METHEMOGLOBINEMIA, TYPE I
|
|
Polymicrogyria, bilateral perisylvian, autosomal recessive
|
|
Advanced sleep phase syndrome, familial
|
|
Deafness, autosomal dominant 15
|
|
Hypoplastic enamel-onycholysis-hypohidrosis syndrome
|
A syndrome that affects the teeth, nails, hair, and/or skin. It is characterized by absence (hypodontia) and/or malformation of certain primary (deciduous) and secondary (permanent) teeth occurring in association with improper development of the nails, particularly the toenails.
|
Spinocerebellar ataxia autosomal recessive with axonal neuropathy
|
|
Bardet-Biedl syndrome 9
|
|
Bardet-Biedl syndrome 8
|
|
Deafness, autosomal dominant 12
|
|
Deafness, autosomal dominant 13
|
|
Bardet-Biedl syndrome 5
|
|
Bardet-Biedl syndrome 4
|
|
Bardet-Biedl syndrome 7
|
|
Bardet-Biedl syndrome 6
|
|
Bardet-Biedl syndrome 1
|
|
Jarcho-Levin syndrome
|
A dysostosis that results_in abnormal development located_in vertebrae or located_in ribs. The bones of the spine do not develop properly, which causes them to be misshapen and abnormally joined together.
|
Bardet-Biedl syndrome 2
|
|
Ataxia-telangiectasia-like disorder 2
|
|
Cornelia de Lange syndrome 3
|
|
Primary pulmonary hypertension 4
|
|
Dowling-Degos disease 2
|
|
Primary pulmonary hypertension 2
|
|
Cornelia de Lange syndrome 4
|
|
Cornelia de Lange syndrome 5
|
|
C3hex, ability to smell
|
|
Pseudoexfoliation glaucoma
|
OMIM mapping confirmed by DO. [SN].
|
Tay-Sachs disease, B1 variant
|
|
Arrhythmogenic right ventricular cardiomyopathy
|
An intrinsic cardiomyopathy that is characterized by hypokinetic areas involving the free wall of the right ventricle, with fibrofatty replacement of the right ventricular myocardium, with associated arrhythmias originating in the right ventricle.
|
Tooth agenesis, selective, X-linked, 1
|
|
Schnyder crystalline corneal dystrophy
|
|
Tyrosinase-negative oculocutaneous albinism
|
Oculocutaneous albinism type 1A (OCA1A) is the most severe form of OCA (see this term), where no melanin is produced, and is characterized by white hair and skin, blue, fully translucent irises, nystagmus and misrouting of the optic nerves.
|
Autosomal recessive Dejerine-Sottas syndrome
|
|
Candidiasis, familial, 2
|
|
Candidiasis, familial, 5
|
|
Kabuki syndrome 2
|
|
Tritanopia
|
A color blindness that is characterised by a selective deficiency of blue vision, has_material_basis_in autosomal dominant inheritance of a mutation in the OPN1SW gene and is associated with a deficiency or absence of blue-sensitive cone photoreceptor function.
|
Methylmalonic acidemia with homocystinuria
|
Methylmalonic acidemia with homocystinuria is an inborn error of vitamin B12 (cobalamin) metabolism characterized by megaloblastic anemia, lethargy, failure to thrive, developmental delay, intellectual deficit and seizures. There are four complementation classes of cobalamin defects (cblC, cblD, cblF and cb1J) that are responsible for methylmalonic acidemia - homocystinuria (methylmalonic acidemia - homocystinuria cblC, cblD cblF and cblJ; see these terms).
|
Retinal cone dystrophy 4
|
|
Hypogonadotropic hypogonadism 10 with or without anosmia
|
|
Mast cell disease, systemic
|
|
Coffin Siris/Intellectual Disability
|
|
Hay-Wells syndrome of ectodermal dysplasia
|
|
ACTH resistance
|
|
Bombay phenotype
|
|
Polycystic kidney disease, adult type
|
|
Immunodeficiency 31C
|
|
Colorblindness, partial, deutan series
|
|
Diabetes mellitus type 1
|
|
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)
|
|
Non-ketotic hyperglycinemia
|
An amino acid metabolic disorder that involves abnormally high levels of the amino acid glycine in bodily fluids and tissues.
|
Spherocytosis type 4
|
|
Familial hypokalemia-hypomagnesemia
|
|
Reynolds syndrome
|
Reynolds syndrome (RS) is an autoimmune disorder characterized by the association of primary biliary cirrhosis (PBC) with limited cutaneous systemic sclerosis (lcSSc) (see these terms).
|
Juvenile macular degeneration and hypotrichosis
|
|
Cushing's symphalangism
|
An autosomal dominant disease that is characterized by ankylosis of the proximal interphalangeal joints, carpal and tarsal bone fusion, and conductive deafness.
|
Pseudohermaphroditism, female, with hypokalemia, due to glucocorticoid resistance
|
|
Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant
|
|
Age-related macular degeneration 6
|
|
Age-related macular degeneration 3
|
|
Cardiomyopathy, dilated, 1u
|
|
Emery-dreifuss muscular dystrophy 6
|
|
Myasthenia, limb-girdle, familial
|
|
Apolipoprotein a-i deficiency
|
|
Hereditary motor and sensory neuropathy with optic atrophy
|
|
Microphthalmia, syndromic, 7
|
|
Primary hyperparathyroidism
|
Xref MGI.
|
Immunodeficiency 31a
|
|
Spastic paraplegia 39
|
|
Mental retardation, autosomal recessive 39
|
|
Keratosis follicularis
|
OMIM mapping confirmed by DO. [SN].
|
Glut1 deficiency syndrome 1, autosomal recessive
|
|
Charcot-Marie-Tooth disease dominant intermediate 3
|
|
Atrial fibrillation, familial, 13
|
|
Atrial fibrillation, familial, 12
|
|
Atrial fibrillation, familial, 11
|
|
Dilated cardiomyopathy 1EE
|
|
Atrial fibrillation, familial, 17
|
|
Atrial fibrillation, familial, 16
|
|
Atrial fibrillation, familial, 15
|
|
Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
|
Hypochondrogenesis
|
An osteochondrodysplasia that has_material_basis_in a mutation in the COL2A1 gene which affects bone growth and results_in a small body, hydrops fetalis, and abnormal ossification located_in vertebral column or located_in pelvis. The disease has_symptom enlarged abdomen.
|
Joubert syndrome 12/15, digenic
|
|
Serkal syndrome
|
|
Hereditary gingival fibromatosis
|
Hereditary gingival fibromatosis (HGF) is a rare benign, slowly progressive, non-inflammatory fibrous hyperplasia of the maxillary and mandibular gingivae that generally occurs with the eruption of the permanent (or more rarely the primary) dentition or even at birth. It presents as a localized or generalized, smooth or nodular overgrowth of the gingival tissues of varying severity. It can be isolated, with autosomal dominant inheritance, or as part of a syndrome.
|
Neutral lipid storage disease with myopathy
|
|
Thrombophilia due to thrombomodulin defect
|
|
Marinesco-Sjögren syndrome
|
|
Seckel syndrome 8
|
|
Ovarian dysgenesis 1
|
|
NIEMANN-PICK DISEASE, TYPE C1, JUVENILE FORM
|
|
Dilated cardiomyopathy 3B
|
|
Seckel syndrome 2
|
|
Seckel syndrome 1
|
|
Seckel syndrome 7
|
|
Deafness, autosomal dominant nonsyndromic sensorineural 17
|
|
Haemorrhagic telangiectasia 1
|
|
WFS1-Related Disorders
|
|
Deafness, autosomal recessive 86
|
|
Sandhoff disease, infantile
|
|
Gamma-aminobutyric acid transaminase deficiency
|
A gamma-amino butyric acid metabolism disorder that is characterized by a defect in the gene coding for gamma-aminobutyrate transaminase, which is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde.
|
Deafness, autosomal recessive 81
|
|
Ring dermoid of cornea
|
|
Oculodentodigital dysplasia, autosomal recessive
|
|
Myeloperoxidase deficiency
|
|
Deafness, autosomal recessive 89
|
|
Deafness, autosomal recessive 88
|
|
Dyskeratosis congenita, autosomal dominant, 3
|
|
Hemophagocytic lymphohistiocytosis, familial, 5
|
|
Hemophagocytic lymphohistiocytosis, familial, 4
|
|
Neu-laxova syndrome 2
|
|
Urofacial syndrome 2
|
|
Hemophagocytic lymphohistiocytosis, familial, 3
|
|
Hemophagocytic lymphohistiocytosis, familial, 2
|
|
Mitochondrial phosphate carrier deficiency
|
|
Hereditary factor XI deficiency disease
|
|
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, SEVERE
|
|
Porphobilinogen synthase deficiency
|
|
Gordon's syndrome
|
|
Lynch syndrome:Lynch syndrome
|
|
Arts syndrome
|
An X-linked disease that is characterized by profound congenital sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk of infection and has_material_basis_in mutations of the PRPS1 gene.
|
Thyroid dyshormonogenesis 1
|
|
Myasthenia, limb-girdle, with tubular aggregates
|
|
Renal carnitine transport defect
|
|
Thyroid dyshormonogenesis 6
|
|
Nephronophthisis-like nephropathy 1
|
|
Noonan syndrome 8
|
|
Noonan syndrome 5
|
|
Noonan syndrome 4
|
|
Noonan syndrome 7
|
|
Noonan syndrome 6
|
|
Noonan syndrome 1
|
|
Noonan syndrome 3
|
|
Microcephalic osteodysplastic primordial dwarfism type 2
|
|
Vesicoureteral reflux 2
|
|
Vesicoureteral reflux 3
|
|
Coloboma of optic disc
|
|
Left ventricular noncompaction 8
|
|
Spondyloepiphyseal dysplasia with congenital joint dislocations
|
A spondyloepimetaphyseal dysplasia that is characterized by short stature of prenatal onset, joint dislocations (knees, hips, radial heads), club feet, and limitation of range of motion that can involve all large joints.
|
Left ventricular noncompaction 6
|
|
Left ventricular noncompaction 7
|
|
Vesicoureteral reflux 8
|
|
Left ventricular noncompaction 5
|
|
Diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
|
McKusick Kaufman syndrome
|
|
Pontocerebellar hypoplasia type 2D
|
NT MGI.
|
Atrophia bulborum hereditaria
|
Norrie disease (ND) is a rare X-linked genetic vitreoretinal condition characterized by abnormal retinal development with congenital blindness. Common associated manifestations include sensorineural hearing loss and developmental delay, intellectual disability and/or behavioral disorders.
|
Elliptocytosis 3
|
|
Orofacial cleft 11
|
|
Autoimmune polyglandular syndrome type 1, autosomal dominant
|
|
Nemaline myopathy 10
|
|
Rubinstein-Taybi syndrome
|
An autosomal dominant disease characterized by short stature, moderate to sever intellectual disability, distinctive facial features and broad thumbs and first toes; additionally it can include eye abnormalities, heart and kidney defects, dental problems and obesity.
|
Nephrotic syndrome, type 5, with or without ocular abnormalities
|
|
Very long chain acyl-CoA dehydrogenase deficiency
|
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is an inherited disorder of mitochondrial long-chain fatty acid oxidation with a variable presentation including: cardiomyopathy, hypoketotic hypoglycemia, liver disease, exercise intolerance and rhabdomyolysis.
|
MUCOPOLYSACCHARIDOSIS, TYPE VI, SEVERE
|
|
Optic nerve hypoplasia, bilateral
|
|
Ventricular fibrillation, paroxysmal familial, 2
|
|
IRAK4 deficiency
|
|
Diabetes mellitus type 2
|
|
Infantile hypophosphatasia
|
|
Leukocyte adhesion deficiency
|
OMIM mapping confirmed by DO. [SN].
|
FG syndrome 2
|
|
Muscular dystrophy, congenital, due to ITGA7 deficiency
|
|
Hereditary leiomyomatosis and renal cell cancer
|
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a hereditary cancer syndrome characterized by a predisposition to cutaneous and uterine leiomyomas and, in some families, to renal cell cancer.
|
Loeys-Dietz syndrome, type 2
|
|
Colchicine resistance
|
|
Retinitis pigmentosa 37
|
|
Split-hand/foot malformation 6
|
|
Keratosis pilaris decalvans
|
|
Xeroderma pigmentosum, variant type
|
|
Hypogonadotrophic hypogonadism
|
Hypogonadotropic hypogonadism is characterized by reduced function of the gonads (testes in males or ovaries in females) and results from the absence of the gonadal stimulating pituitary hormones: follicle stimulating hormone (FSH) and luteinizing hormone (LH).
|
Methemoglobinemia type 2
|
|
Maple syrup urine disease type 1A
|
|
Dysgnathia complex
|
|
Glycogen storage disease, type VII
|
OMIM mapping confirmed by DO. [SN].
|
Stickler syndrome type 1
|
|
Peroxisome biogenesis disorder 2A
|
|
Glycogen storage disease XV
|
|
Age-related macular degeneration 11
|
|
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4
|
A mitochondrial metabolism disease that has material basis in mutation in the ATP5A1 gene on chromosome 18q.
|
Hemoglobin H disease, nondeletional
|
|
Age-related macular degeneration 14
|
|
Recessive dystrophic epidermolysis bullosa
|
|
Potassium aggravated myotonia
|
Potassium-aggravated myotonia (PAM) is a muscular channelopathy presenting with a pure myotonia dramatically aggravated by potassium ingestion, with variable cold sensitivity and no episodic weakness. This group includes three forms: myotonia fluctuans, myotonia permanens, and acetazolamide-responsive myotonia (see these terms).
|
Axenfeld-rieger anomaly
|
|
Generalized epilepsy with febrile seizures plus, type 9
|
|
Deafness, autosomal recessive 48
|
|
Cortisone reductase deficiency 2
|
|
Hypomyelination with brainstem and spinal cord involvement and leg spasticity
|
|
Generalized epilepsy with febrile seizures plus, type 1
|
|
Splenic hypoplasia
|
|
Generalized epilepsy with febrile seizures plus, type 2
|
|
Multiple endocrine neoplasia, type 2a
|
An autosomal dominant disease characterized by medullary carcinoma of the thyroid, pheochromocytoma, hyperparathyroidism, and occasionally cutaneous lichen amyloidosis.
|
Glycogen content in skeletal muscle, increased
|
|
Polyglandular autoimmune syndrome, type 1
|
|
Atrioventricular septal defect 4
|
|
Atrioventricular septal defect 5
|
|
Cholestasis of pregnancy
|
|
Short-rib thoracic dysplasia 10 with or without polydactyly
|
|
Marfan's syndrome:Marfan's syndrome
|
|
Arginine:glycine amidinotransferase deficiency
|
An amino acid metabolic disorder that has_material_basis_in a mutation in the GATM gene resulting in deficiency of arginine:glycine amidinotransferase which then limits creatine synthesis.
|
Ciliary dyskinesia, primary, 13
|
|
Ciliary dyskinesia, primary, 12
|
|
Ciliary dyskinesia, primary, 11
|
|
Ciliary dyskinesia, primary, 10
|
|
Ciliary dyskinesia, primary, 17
|
|
Ciliary dyskinesia, primary, 16
|
|
Ciliary dyskinesia, primary, 15
|
|
Ciliary dyskinesia, primary, 14
|
|
Pyruvate kinase deficiency
|
|
Ciliary dyskinesia, primary, 19
|
|
Ciliary dyskinesia, primary, 18
|
|
Osteogenesis imperfecta type 13
|
|
Methionine adenosyltransferase deficiency, autosomal dominant
|
|
Deafness, autosomal recessive 2
|
|
Dermatofibrosis lenticularis disseminata
|
|
Cyclical neutropenia
|
OMIM mapping confirmed by DO. [SN].
|
Greenberg dysplasia
|
|
Ventricular tachycardia, catecholaminergic polymorphic, 2
|
|
Familial platelet disorder with associated myeloid malignancy
|
|
Bernard-Soulier syndrome, type A1
|
|
Pseudoprimary hyperaldosteronism
|
|
Muscle AMP deaminase deficiency
|
|
Infantile GM1 gangliosidosis
|
GM1 gangliosidosis type 1 is the severe infantile form of GM1 gangliosidosis (see this term) with variable neurological and systemic manifestations.
|
Arthrogryposis renal dysfunction cholestasis syndrome
|
|
Retinitis pigmentosa 70
|
|
Pachyonychia congenita type 2
|
|
Severe combined immunodeficiency disease
|
|
Dihydropyrimidinase deficiency
|
Dihydropyrimidinase (DPD) deficiency is a very rare pyrimidine metabolism disorder with a variable clinical presentation including gastrointestinal manifestations (feeding problems, cyclic vomiting, gastroesophageal reflux, malabsorption with villous atrophy), hypotonia, intellectual deficit, seizures, and less frequently growth retardation, failure to thrive, microcephaly and autism. Asymptomatic cases are also reported. DPD deficiency increases the risk of 5-FU toxicity.
|
Deafness, autosomal dominant 2b
|
|
EEM syndrome
|
|
Dimethylglycine dehydrogenase deficiency
|
Dimethylglycine dehydrogenase deficiency is an extremely rare autosomal recessive glycine metabolism disorder characterized clinically in the single reported case to date by muscle fatigue and a fish-like odor.
|
Cardiofaciocutaneous syndrome 2
|
|
Deficiency of hydroxymethylglutaryl-CoA lyase
|
|
Familial erythrocytosis, 1
|
|
3-Methylglutaconic aciduria
|
|